[
    {
        "question_id": 0,
        "patient_id": "7562e458-cfcd-2ab3-f1f7-41665db2af63",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute viral pharyngitis (disorder) taking Naproxen sodium 220 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 12532 phenotype_protein 6335.",
        "llm_answer": "When considering the use of Naproxen sodium for a patient with acute viral pharyngitis, here are some risks to consider:\n\n*   **Gastrointestinal Issues:** Naproxen, as an NSAID, can cause stomach upset, ulcers, or bleeding, especially with long-term use.\n\n*   **Cardiovascular Risks:** NSAIDs can increase the risk of heart attack or stroke, particularly in those with pre-existing heart conditions.\n\n*   **Kidney Problems:** Naproxen can potentially harm the kidneys, especially in individuals who are dehydrated or have kidney disease.\n\n*   **Bleeding Risk:** Naproxen can interfere with blood clotting and increase the risk of bleeding.\n\n*   **Drug Interactions:** Naproxen can interact with other medications, such as blood thinners or certain antidepressants.\n\n*   **Allergic Reactions:** Although less common, some individuals may experience an allergic reaction to Naproxen.\n\nSince the patient has a history of substance use (\"Misuses drugs (finding)\") and reports of violence in the environment (\"Reports of violence in the environment (finding)\"), it's important to consider the potential for misuse or accidental overdose, as well as the impact of these social factors on their overall health and ability to adhere to medication instructions.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains facts about the relationship between phenotypes and proteins, and does not contain information about the risks associated with taking Naproxen sodium 220 MG Oral Tablet for Acute viral pharyngitis.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 1,
        "patient_id": "4cc043f9-1872-e18b-d387-2eb492f075a7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Body Weight: 69.2 progress for a patient with Misuses drugs (finding)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I am unable to answer this question. My knowledge base does not contain information about the progression of Body Weight with Misuses drugs (finding), or the relationship between the provided facts and the question.\n",
        "rag_answer": "I cannot determine how the symptom 'Body Weight: 69.2' might progress specifically for a patient with 'Misuses drugs (finding)' based on the provided knowledge graph. The knowledge graph focuses on protein and disease relationships, drug contraindications, and cellular components, but it does not contain information about how drug misuse directly impacts body weight.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 2,
        "patient_id": "94cecba2-18b0-72a1-334d-427ecbf4fdff",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Pain severity - 0-10 verbal numeric rating [Score] - Reported: 3.0 progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided information does not contain details about how pain severity might progress specifically for a patient with only primary school education. Also, the additional information about DB01556 contraindications doesn't seem relevant to the question about pain progression.\n",
        "rag_answer": "I cannot predict how the symptom \"Pain severity - 0-10 verbal numeric rating [Score] - Reported: 3.0\" might progress for this patient, nor can I use the provided knowledge graph to do so. The knowledge graph contains drug-related information (contraindications and drug-drug interactions for a drug with ID DB01556) and is not related to pain progression or the impact of education level on pain.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 3,
        "patient_id": "15e34bee-9f5e-e034-3e49-1406647f3b4d",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Triglycerides: 199.0 progress for a patient with Alcoholism? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "I cannot answer this question. While I am able to see that the patient has a symptom of triglycerides, a condition of alcoholism, and elevated triglycerides, I am missing the ability to determine how alcoholism might progress the symptom triglycerides.\n",
        "rag_answer": "I am unable to answer this question. The patient's profile does include Alcoholism and Triglycerides level. However, I do not have the ability to predict how Triglycerides level might progress.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 4,
        "patient_id": "d31efc1d-0594-002a-61f2-4eee3a4c8cec",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Urea Nitrogen: 11.5 progress for a patient with Stress (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer your question, as the provided knowledge graph does not contain information about urea nitrogen and stress.",
        "rag_answer": "I am sorry, I cannot answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556) and does not include information about the progression of Urea Nitrogen levels in relation to stress.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 5,
        "patient_id": "ed1f5200-78a5-de4b-0c49-bf64c98ecae8",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What address do you live at?: 790 Hamill Promenade progress for a patient with Viral sinusitis (disorder)?",
        "llm_answer": "I am unable to predict how the symptom \"What address do you live at?: 790 Hamill Promenade\" might progress, as it is not a symptom and is unrelated to Viral sinusitis (disorder). Addresses do not progress.\n",
        "rag_answer": "I am unable to predict how the symptom \"What address do you live at?: 790 Hamill Promenade\" might progress, as it is not a symptom but rather an address. I can answer questions about symptoms related to Viral sinusitis (disorder), if you have any.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 6,
        "patient_id": "5c68d61d-ff44-a6f2-fabd-1cf309196a1d",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Chloride: 102.0 progress for a patient with Stress (finding)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I am unable to answer this question. The provided knowledge graph does not contain any information about the relationship between chloride levels, stress, and potential disease progression.\n",
        "rag_answer": "I cannot predict how the symptom \"Chloride: 102.0\" might progress specifically for a patient with stress based on the provided information. The knowledge graph includes facts about diseases, proteins, and biological processes, but it doesn't contain information about the direct relationship between stress and chloride levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 7,
        "patient_id": "6666bcfc-4f47-9993-ddfe-2691afdc4696",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute bacterial sinusitis (disorder) taking Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]?",
        "llm_answer": "Here are some risks to consider for a patient with acute bacterial sinusitis taking Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]:\n\n*   **Respiratory Depression:** Oxycodone, an opioid, can cause significant respiratory depression, especially in elderly or debilitated patients, and those with pulmonary disease like emphysema which this patient has. This risk is elevated with higher doses or concurrent use of other CNS depressants.\n*   **Abuse and Misuse:** Oxycodone is an opioid with a high potential for abuse, even in abuse-deterrent formulations. Assess the patient's risk for opioid abuse, especially considering their history of criminal record, reports of violence in the environment, and DAST-10 score.\n*   **Dependence and Withdrawal:** Prolonged use of oxycodone can lead to physical and psychological dependence. Abrupt cessation can trigger withdrawal symptoms.\n*   **Gastrointestinal Effects:** Oxycodone can cause constipation, nausea, and vomiting.\n*   **Central Nervous System (CNS) Effects:** Drowsiness, dizziness, lightheadedness, and impaired cognitive function are possible side effects. Caution patients about activities requiring alertness, such as driving or operating machinery.\n*   **Interactions with Other Medications:** Oxycodone can interact with other CNS depressants (e.g., alcohol, benzodiazepines, antihistamines) increasing the risk of respiratory depression and sedation.\n*   **Risk of Overdose:** Overdose can occur with excessive doses, especially when combined with other CNS depressants.\n*   **Hypotension:** Opioids like oxycodone can cause hypotension, especially in patients with hypovolemia or those taking medications that lower blood pressure.\n*   **Worsening of Sinusitis:** While oxycodone can help with pain, it does not treat the underlying bacterial infection. Inadequate treatment of the infection could lead to complications. Additionally, the patient is also taking acetaminophen/hydrocodone.\n*   **Increased risk of intimate partner violence:** The patient has a history of intimate partner violence. Prescribing an opioid such as oxycodone could increase the risk of intimate partner violence.\n\nGiven the patient's conditions, medications, and social factors, careful monitoring and patient education are crucial. Alternatives to opioids for pain management should be considered whenever possible.\n",
        "rag_answer": "Here are some risks to consider for a patient with acute bacterial sinusitis taking Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]:\n\n*   **Respiratory Depression:** Oxycodone can cause significant respiratory depression, especially in individuals with pre-existing respiratory conditions like pulmonary emphysema. This risk is heightened when combined with other medications that depress the central nervous system.\n*   **Addiction and Abuse Potential:** Oxycodone is an opioid with a high potential for abuse and addiction. Patients with a history of substance abuse or those with risk factors such as \"Has a criminal record (finding)\" or \"Reports of violence in the environment (finding)\" may be at higher risk. The \"Abuse-Deterrent\" formulation aims to reduce this risk, but does not eliminate it.\n*   **Central Nervous System (CNS) Depression:** Oxycodone can cause drowsiness, dizziness, and impaired cognitive function. This can be exacerbated by other CNS depressants.\n*   **Gastrointestinal Effects:** Opioids like oxycodone can cause constipation, nausea, and vomiting.\n*   **Interactions:** Oxycodone can interact with other medications, potentially increasing the risk of side effects or reducing the effectiveness of either medication.\n*   **Risk of Overdose:** Overdose can occur, leading to respiratory depression, coma, and death.\n*   **Tolerance and Dependence:** With prolonged use, tolerance to oxycodone can develop, requiring higher doses to achieve the same level of pain relief. Physical dependence can also occur, leading to withdrawal symptoms if the medication is abruptly discontinued.\n*   **Withdrawal Symptoms:** Abrupt cessation of oxycodone can lead to withdrawal symptoms such as restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, and goosebumps.\n*   **Intimate Partner Abuse:** Given the patient's history of being a victim of intimate partner abuse, it's important to consider whether the medication could be misused by an abuser or if access to the medication could create a dangerous situation.\n*   **Mental Health:** The patient also reports stress, which could potentially be worsened by opioid use due to its impact on mood and cognitive function.\n\nGiven the patient's history, a non-opioid pain reliever might be a better choice.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 8,
        "patient_id": "b8f0f7fa-c623-67e2-6434-d1ddb63de9df",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Systolic Blood Pressure: 107.0 progress for a patient with Myocardial Infarction? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I cannot predict how Systolic Blood Pressure: 107.0 might progress for a patient with Myocardial Infarction based on the provided information about pathway proteins. I am missing the information required to answer the question.\n",
        "rag_answer": "I cannot predict how Systolic Blood Pressure might progress in a patient with Myocardial Infarction based on the provided knowledge graph. The provided facts relate to protein pathways and drug interactions/contraindications of Nitroglycerin, which are not directly related to predicting the progression of systolic blood pressure in myocardial infarction.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 9,
        "patient_id": "6ad59647-a0db-2a01-dca6-087b48bfb805",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Malignant neoplasm of breast (disorder) taking lisinopril 10 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, the following contraindications (risks) should be considered for a patient taking lisinopril (DB01556):\n\n*   5044\n*   1200_1134_15512_5080_100078\n*   992\n\nIt is important to note that this information is based solely on the provided knowledge graph and may not be exhaustive. A healthcare professional should always be consulted for medical advice.",
        "rag_answer": "Based on the provided information, I can offer some potential considerations:\n\n*   **Lisinopril Contraindications:** The knowledge graph indicates several contraindications for lisinopril (DB01556), represented by numerical codes. Without knowing what these codes stand for, it's difficult to provide specific details. Generally, contraindications are conditions or situations where a drug should not be used.\n\nIt's important to consult with the patient's oncologist and/or primary care physician for a comprehensive risk assessment. They can consider the patient's full medical history, current health status, and potential interactions with other medications or treatments.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 10,
        "patient_id": "4d3204cc-fbbe-77ba-8a8c-ea49d0422d33",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Total Cholesterol: 192.3 progress for a patient with Limited social contact (finding)?",
        "llm_answer": "It's difficult to predict precisely how total cholesterol will progress based solely on limited social contact. However, I can offer some potential connections:\n\n*   **Indirect effects:** Limited social contact can sometimes lead to unhealthy lifestyle choices. For example, it might contribute to a less active lifestyle, poorer diet, or increased stress, all of which can negatively impact cholesterol levels.\n*   **Mental health:** Social isolation can be linked to depression and anxiety. These conditions, in turn, might influence health behaviors affecting cholesterol.\n*   **Lack of support:** Individuals with limited social contact may have less support for managing their health, including adhering to dietary recommendations or exercise plans that could help control cholesterol.\n\nIt's important to note that these are potential associations, and the actual progression of cholesterol levels will depend on a variety of individual factors.",
        "rag_answer": "The patient's total cholesterol is 192.3 mg/dL. The progression of this symptom in a patient with limited social contact is difficult to predict with certainty, as it depends on various factors, including diet, exercise, genetics, and other underlying health conditions. However, limited social contact can contribute to poorer health outcomes in several ways. It may be associated with unhealthy lifestyle choices, such as poor diet and lack of exercise, which can negatively impact cholesterol levels. Social isolation can also lead to increased stress and depression, which may also affect cholesterol levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 11,
        "patient_id": "233e8b42-45d4-726a-65c9-2490d752beda",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Stress is when someone feels tense  nervous  anxious or can't sleep at night because their mind is troubled. How stressed are you?: Not at all progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "This is a complex question that requires a nuanced understanding of the patient's social determinants of health and their potential impact on stress levels. Here's a breakdown of how the patient's limited education might influence their stress, and how it might progress over time:\n\n**How Limited Education Can Influence Stress:**\n\n*   **Socioeconomic Factors:** Lower educational attainment is often linked to lower-paying jobs, unemployment, and financial insecurity. The patient's profile indicates part-time employment and concerns about housing, which are likely exacerbated by limited education, leading to significant stress.\n*   **Health Literacy:** Difficulty understanding health information and navigating the healthcare system can increase anxiety and stress related to managing chronic conditions like hypertension, sinusitis, osteoarthritis, fibromyalgia and back pain.\n*   **Social Support:** The patient has limited social contact and social isolation. Education can influence social networks and access to resources, potentially limiting their support system and increasing feelings of isolation and stress.\n*   **Coping Mechanisms:** Education can equip individuals with better problem-solving skills and coping mechanisms for dealing with stress. Without these skills, the patient may be more vulnerable to the negative impacts of stress.\n*   **Abuse and Trauma:** The patient is a victim of intimate partner abuse, and this combined with limited education, can create a cycle of vulnerability and increased stress.\n\n**Potential Progression of Stress (Without Intervention):**\n\n*   **Chronic Stress:** Without intervention, the patient's stress could become chronic, leading to or worsening existing mental health conditions like anxiety and depression, as indicated by their GAD-7 and PHQ-2 scores.\n*   **Physical Health Impact:** Chronic stress can exacerbate physical health problems like hypertension, fibromyalgia, and chronic pain, leading to a vicious cycle of worsening symptoms and increased stress.\n*   **Increased Healthcare Utilization:** The patient may require more frequent medical care for stress-related health problems, further straining their resources and increasing stress.\n*   **Substance Use:** As indicated by the positive drug screen, the patient might turn to substance use as a maladaptive coping mechanism, leading to further health and social problems.\n*   **Decreased Quality of Life:** The patient's overall quality of life, as measured by QALY and QOLS scores, is likely to decline further if stress is not addressed.\n\n**Recommendations and Interventions:**\n\nGiven the patient's complex situation, a comprehensive and multidisciplinary approach is needed:\n\n*   **Address Social Determinants of Health:** Connect the patient with resources to address housing insecurity, financial difficulties, and food insecurity. Social workers can be invaluable in this process.\n*   **Improve Health Literacy:** Provide patient education materials in plain language, and consider using teach-back methods to ensure understanding.\n*   **Enhance Social Support:** Encourage participation in social activities and support groups to combat social isolation.\n*   **Mental Health Support:** Provide counseling or therapy to address stress, anxiety, and the trauma of intimate partner abuse. Cognitive Behavioral Therapy (CBT) and mindfulness-based interventions can be helpful.\n*   **Pain Management:** Optimize pain management strategies to reduce pain-related stress and improve function.\n*   **Hypertension Management:** Closely monitor and manage hypertension, as stress can significantly impact blood pressure control.\n*   **Substance Abuse Treatment:** Offer resources and support for substance abuse treatment, if appropriate.\n\n**Important Considerations:**\n\n*   **Individualized Approach:** The specific interventions should be tailored to the patient's individual needs and preferences.\n*   **Cultural Sensitivity:** Be mindful of cultural factors that may influence the patient's experience of stress and their willingness to seek help.\n*   **Ongoing Monitoring:** Regularly assess the patient's stress levels and adjust the treatment plan as needed.\n\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not provide information about the relationship between educational attainment and stress levels.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 12,
        "patient_id": "9e83f507-cebb-a7e5-5a9b-aea2d6d2c8f4",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Part-time employment (finding) taking Verapamil Hydrochloride 40 MG? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5098; DB00304 contraindication 11057; DB00304 contraindication 20671.",
        "llm_answer": "Here are some risks to consider for a patient with part-time employment taking Verapamil Hydrochloride 40 MG, based on the provided information:\n\n*   **Contraindications:** The knowledge graph indicates that Verapamil (DB00304) has contraindications with codes 5098, 11057, and 20671. To provide specific risks, I would need to look up what these codes represent in a medical database. Common contraindications for verapamil include severe hypotension, sick sinus syndrome, and second- or third-degree AV block (unless a functioning pacemaker is present).\n",
        "rag_answer": "Some risks to consider for a patient taking Verapamil Hydrochloride 40 MG (DB00304) include contraindications related to the conditions 5098, 11057, and 20671. Please consult with a healthcare professional for a complete list of risks and contraindications.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 13,
        "patient_id": "3a39b848-0e35-b237-2813-dc81be049590",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 progress for a patient with Received certificate of high school equivalency (finding)?",
        "llm_answer": "I cannot predict how Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 might progress for a patient with Received certificate of high school equivalency (finding).",
        "rag_answer": "I am unable to predict how the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 might progress for a patient with Received certificate of high school equivalency (finding).",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 14,
        "patient_id": "753bd740-7680-1035-0692-edaf6d545dbe",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Viral sinusitis (disorder) taking Simvastatin 20 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5010; DB00304 contraindication 5068; DB00304 contraindication 6652_3678_1090_3672_3673_3676_3677_3679_6803.",
        "llm_answer": "I am unable to answer the question. The provided knowledge graph does not contain information about the risks of taking Simvastatin 20 MG Oral Tablet when you have Viral sinusitis (disorder).\n",
        "rag_answer": "I am unable to answer this question. The provided medical knowledge does not contain information about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": false
    },
    {
        "question_id": 15,
        "patient_id": "541118ce-e381-8922-83b7-3547e3f30076",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Normal pregnancy taking lisinopril 10 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Lisinopril is contraindicated during pregnancy (Normal pregnancy, Fetus with unknown complication, Miscarriage in first trimester).\n",
        "rag_answer": "Lisinopril (DB01556) is contraindicated (contraindication) in pregnancy (5044, 1200_1134_15512_5080_100078, 992). Therefore, Lisinopril should not be used during normal pregnancy.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 16,
        "patient_id": "90e6fe32-d67b-96cc-bbd6-94aa94d0b20c",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Social isolation (finding) taking amLODIPine 2.5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the provided information, here's what I can tell you regarding risks for a patient with social isolation taking amlodipine:\n\n*   **Amlodipine Contraindications:** The knowledge graph includes the following amlodipine (DB01556) contraindications: 5044, 1200_1134_15512_5080_100078, and 992. To give a complete answer, I would need to know what these codes mean.\n\nIt's important to note:\n\n*   **Social Isolation:** Social isolation can impact medication adherence and overall well-being. It's crucial to ensure the patient has support to manage their medications and address any potential side effects.\n\n**Disclaimer:** This information should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment.\n",
        "rag_answer": "Based on the provided information, the knowledge graph indicates that amLODIPine (DB01556) has several contraindications (5044, 1200_1134_15512_5080_100078, 992, etc.) and drug-drug interactions. However, none of the listed contraindications specifically mention social isolation. It's crucial to consult a comprehensive medical reference or a healthcare professional to determine the specific risks associated with amLODIPine in patients with social isolation. Social isolation itself might influence medication adherence or the patient's ability to recognize and report adverse effects, which should be considered.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 17,
        "patient_id": "5f5de9db-8676-bafc-06d3-cc24416c72b4",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom In the past year  have you spent more than 2 nights in a row in a jail  prison  detention center  or juvenile correctional facility?: No progress for a patient with Acute bronchitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The symptom \"In the past year have you spent more than 2 nights in a row in a jail prison detention center or juvenile correctional facility?: No\" does not have a direct impact on the progress of Acute Bronchitis.\n",
        "rag_answer": "The symptom \"In the past year have you spent more than 2 nights in a row in a jail prison detention center or juvenile correctional facility?: No\" does not directly relate to the progress of Acute Bronchitis. It's a social history question that could be relevant to overall health and well-being but wouldn't typically be used to assess the progress of bronchitis treatment. The provided medical knowledge graph also does not contain information related to acute bronchitis or incarceration.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 18,
        "patient_id": "dc66d338-11bd-8ca6-d020-7b0bc2acf8a1",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Polyp of colon taking Acetaminophen 325 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer the question. The provided information does not include risks associated with Polyp of colon or Acetaminophen 325 MG Oral Tablet. The knowledge graph facts provided are insufficient to answer the question.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph includes information about drug interactions and contraindications for a drug with ID DB01556. To provide an answer, the drug ID for Acetaminophen 325 MG Oral Tablet is needed.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 19,
        "patient_id": "b9f5b378-f8cb-7c98-b8e9-0dee64335112",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Tubal pregnancy taking Camila 28 Day Pack? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, Camila 28 Day Pack (DB01556) is contraindicated in the following conditions:\n\n*   **5044:** This code is not specific enough to determine the risk.\n*   **1200_1134_15512_5080_100078:** This code is not specific enough to determine the risk.\n*   **992:** This code is not specific enough to determine the risk.\n\nI am unable to answer due to a lack of specific information about risks.",
        "rag_answer": "Based on the provided information:\n\n*   **Camila 28 Day Pack** contains norethindrone, which has DrugBank ID DB01556.\n*   The knowledge graph (PrimeKG) lists several contraindications for DB01556 (norethindrone), including \"5044\", \"1200\\_1134\\_15512\\_5080\\_100078\", and \"992\". However, the specific conditions these codes represent are not defined in the given context.\n\nGiven the patient's profile, the most relevant risk to consider is the **Tubal pregnancy**. Ectopic pregnancy is a contraindication for DB01556.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 20,
        "patient_id": "2e313061-dc85-c9a1-2442-d29aa9fc4798",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Shock (disorder) taking losartan potassium 50 MG Oral Tablet?",
        "llm_answer": "Based on the provided information, here are some risks to consider for a patient with shock taking Losartan:\n\n*   **Hypotension:** Both shock and Losartan can cause low blood pressure. Combining them could lead to dangerously low blood pressure, potentially worsening the shock.\n\nIt is important to note that this information is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.\n",
        "rag_answer": "Here are some risks to consider for a patient with shock taking losartan potassium:\n\n*   **Hypotension:** Losartan can lower blood pressure. In a patient with shock, who may already have low blood pressure, losartan could exacerbate this, leading to further compromise of vital organ perfusion.\n*   **Hyperkalemia:** Losartan can increase potassium levels. Shock can sometimes be associated with kidney dysfunction, which can also lead to increased potassium. The combination can result in dangerous hyperkalemia.\n*   **Acute Kidney Injury:** Because losartan affects blood pressure and kidney function, it could worsen kidney injury in the setting of shock.\n*   **Drug Interactions:** Losartan can interact with other medications that might be used in the treatment of shock, potentially leading to unpredictable effects.\n\nIt is important to note that the decision to administer losartan to a patient in shock should be made carefully, considering the potential risks and benefits, and with close monitoring of the patient's blood pressure, kidney function, and potassium levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 21,
        "patient_id": "7423e440-7a9a-7bd7-63bd-9da82a500912",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Received certificate of high school equivalency (finding) taking Naproxen sodium 220 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. My knowledge base does not have sufficient information about risks to consider for a patient with Received certificate of high school equivalency (finding) taking Naproxen sodium 220 MG Oral Tablet.",
        "rag_answer": "I am unable to answer the question. The patient's profile includes 'Received certificate of high school equivalency (finding)' which is not relevant in this context. The question is asking about risks associated with taking Naproxen, and there is no DrugBank ID that matches 'Naproxen sodium 220 MG Oral Tablet' in the knowledge graph.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 22,
        "patient_id": "fc88755b-6767-bfb6-aa78-584a66b8a139",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Part-time employment (finding) taking Digoxin 0.125 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 3784 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4635 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 disease_protein 5010.",
        "llm_answer": "Based on the available information, I cannot provide specific risks associated with part-time employment and Digoxin use. My knowledge base primarily includes the patient's conditions, medications, lab results, social history, and numerical scores related to various health assessments. Additionally, the provided knowledge graph does not seem to contain information related to employment status or medication risks.\n",
        "rag_answer": "I can not answer this question. The provided knowledge graph does not contain information about risks associated with Digoxin or part-time employment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 23,
        "patient_id": "f20df06a-4d56-c80d-95c2-a548c65407f7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Pain severity - 0-10 verbal numeric rating [Score] - Reported: 2.0 progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: 10898 disease_protein 5649; 995 disease_protein 5090_13498_8414_10897_33312_10943_11552_14092_12054_11960_11280_11294_11295_11298_11307_11498_12879_13089_13506; 995 cellcomp_protein 5737.",
        "llm_answer": "I am unable to predict how the symptom of pain severity might progress, as my knowledge base does not contain information on the progression of pain based on education level.\n",
        "rag_answer": "Based on the patient's profile, their pain severity has been reported at different times as 2.0, 3.0, 1.0 and 4.0. I am unable to predict the future progression of the symptom.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 24,
        "patient_id": "9908c417-0d2f-3873-face-1036e1de4ca0",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom DALY: 46.0 progress for a patient with Risk activity involvement (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 1265.",
        "llm_answer": "I am unable to answer this question. The provided information does not contain enough details about the progression of symptom DALY: 46.0 or the impact of \"Risk activity involvement (finding)\" on its progression.\n",
        "rag_answer": "I am sorry, I cannot answer this question. The provided information does not include details on how \"Risk activity involvement (finding)\" might affect the progression of the symptom \"DALY: 46.0\". The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), which is not directly relevant to the question about symptom progression in relation to risk activity involvement.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 25,
        "patient_id": "7d4b6d95-1852-4e50-06f6-3af6262505f6",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Second degree burn taking Acetaminophen 325 MG Oral Tablet [Tylenol]? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "I am unable to answer this question, as I cannot access external knowledge graphs or databases.\n",
        "rag_answer": "Based on the information provided, I cannot directly assess the risks of taking Acetaminophen for a second-degree burn. However, I can provide some general considerations:\n\n*   **Acetaminophen (Tylenol)**: This is a common pain reliever and fever reducer.\n*   **Second-degree burn**: This type of burn involves damage to the epidermis and part of the dermis. Pain management is often a key part of treatment.\n\n**Important Considerations:**\n\n*   **Liver Toxicity:** Acetaminophen can cause liver damage, especially at high doses or in individuals with pre-existing liver conditions.\n\n**Given the limitations of the provided information, it's essential to consult with a healthcare professional for personalized medical advice.** They can assess the patient's specific situation, including the severity of the burn, other medical conditions, and current medications, to determine the most appropriate and safe pain management strategy.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 26,
        "patient_id": "43a3e92e-50b8-1c12-6381-c4d240fe8fa7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Calcium: 9.4 progress for a patient with Limited social contact (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. I am unable to predict how calcium levels may progress based on social contact, and the provided knowledge graph does not contain relevant information.\n",
        "rag_answer": "I cannot answer this question. The provided knowledge graph contains drug interactions and contraindications for a specific drug (Meperidine Hydrochloride, DB01556). It does not contain any information about the progression of calcium levels in patients with limited social contact.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 27,
        "patient_id": "90fda2aa-a5e8-ad7c-f2f7-ecc2bb687514",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Stress (finding) taking Ibuprofen 200 MG Oral Tablet?",
        "llm_answer": "Here are some risks to consider for a patient with stress taking Ibuprofen 200 MG Oral Tablet, based on general medical knowledge:\n\n*   **Gastrointestinal Issues:** Ibuprofen can increase the risk of stomach ulcers, bleeding, and other gastrointestinal problems, especially with long-term use.\n*   **Cardiovascular Risks:** NSAIDs like ibuprofen may increase the risk of heart attack, stroke, and high blood pressure, particularly in those with pre-existing cardiovascular conditions.\n*   **Kidney Problems:** Long-term use of ibuprofen can lead to kidney damage.\n*   **Drug Interactions:** Ibuprofen can interact with other medications, such as blood thinners, aspirin, and certain antidepressants.\n*   **Stress and Pain Management:** While ibuprofen can address pain, it doesn't directly address the underlying stress. It's important to explore comprehensive stress management techniques.\n*   **Mental Health:** While less common, some individuals may experience mood changes or other mental health-related side effects while taking ibuprofen.\n\n**Disclaimer:** This information is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of medical conditions.\n",
        "rag_answer": "Here are some risks to consider for a patient with stress taking Ibuprofen:\n\n*   **Gastrointestinal Issues:** Ibuprofen can increase the risk of stomach ulcers, bleeding, and other gastrointestinal problems. Stress can also exacerbate these issues.\n*   **Cardiovascular Risks:** Ibuprofen, especially at high doses, may increase the risk of heart attack or stroke.\n*   **Kidney Problems:** Long-term use of ibuprofen can lead to kidney damage.\n*   **Drug Interactions:** Ibuprofen can interact with other medications, potentially increasing the risk of side effects.\n*   **Increased Stress Levels:** While ibuprofen can help manage pain and inflammation, it does not address the underlying cause of stress. Relying solely on medication may prevent the patient from seeking more effective stress management strategies.\n*   **Mental Health:** Stress can affect mental health, and some pain relievers can have mood-altering side effects or interact with medications used to treat mental health conditions.\n*   **Addiction:** Prolonged use of pain relievers can lead to dependence and addiction.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 28,
        "patient_id": "8ede6eac-1785-055f-411b-43a507a69f78",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Fall risk level [Morse Fall Scale]: Low Risk (MFS Score 0 - 24) progress for a patient with Acute viral pharyngitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph only includes contraindications for a drug called DB01556. It does not contain information about the progression of fall risk in patients with acute viral pharyngitis.\n",
        "rag_answer": "I cannot directly answer how \"Fall risk level [Morse Fall Scale]: Low Risk (MFS Score 0 - 24)\" might progress specifically for a patient with \"Acute viral pharyngitis (disorder)\" as the provided knowledge graph does not contain information relating to fall risk or acute viral pharyngitis. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 29,
        "patient_id": "8d94532e-87ce-486d-adfc-bfa423b11dd2",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Victim of intimate partner abuse (finding) taking 60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler?",
        "llm_answer": "Several risks should be considered for a patient with a history of intimate partner abuse who is taking Fluticasone propionate/salmeterol:\n\n*   **Exacerbation of Stress and Anxiety:** Intimate partner abuse is often associated with significant stress, anxiety, and depression. Fluticasone propionate/salmeterol, like other corticosteroids, can potentially cause mood changes, anxiety, or depression in some individuals. The existing stress and trauma from abuse could be worsened.\n*   **Adherence to Medication:** The stress and instability caused by intimate partner abuse might affect the patient's ability to consistently adhere to their medication regimen.\n*   **Impact on Overall Health:** Intimate partner abuse has a wide range of negative impacts on physical and mental health, which could complicate the management of their respiratory condition.\n*   **Potential for Medication Misuse/Abuse:** In situations of intimate partner abuse, there is a risk that medications could be misused or withheld by the abuser as a form of control or manipulation.\n*   **Fall Risk:** The patient has a moderate to high fall risk, as indicated by Morse Fall Scale scores ranging from 3 to 95. Some scores indicate moderate risk (25-45) and others indicate high risk (50+). Fluticasone can sometimes cause dizziness, which could increase the risk of falls.\n*   **Social Isolation and Limited Social Contact:** The patient experiences social isolation and limited social contact, seeing or talking to people they care about with varying frequency (from 1 or 2 times a week to 5 or more times a week). This can impact their ability to seek help and support, as well as affect their mental and physical well-being.\n*   **Other Considerations:**\n    *   **Pulmonary Emphysema:** This medication is being used to treat pulmonary emphysema.\n    *   **Malignant neoplasm of breast:** This patient has also been diagnosed with Malignant neoplasm of breast.\n    *   **Body mass index 30+ - obesity (finding):** This patient has also been diagnosed with obesity.",
        "rag_answer": "Okay, based on the patient's profile and the medication they are taking, here's a breakdown of the risks to consider:\n\n**Risks Related to Intimate Partner Abuse and Medication**\n\n*   **Medication Adherence:** Intimate partner abuse can significantly impact a patient's ability to adhere to their medication regimen. Stress, fear, and control by the abuser can all interfere with taking medication as prescribed. This is especially concerning for a medication like Fluticasone/Salmeterol, which requires consistent use for optimal benefit in managing respiratory conditions.\n*   **Mental Health:** Intimate partner abuse is frequently associated with mental health issues like depression, anxiety, and PTSD. These conditions can further complicate medication adherence and overall health management.\n*   **Safety of Medication Storage:** There is a risk the abuser may withhold or tamper with the medication.\n\n**General Risks Associated with Fluticasone/Salmeterol (Advair)**\n\n*   **Cardiovascular Events:** Salmeterol, a component of Advair, is a long-acting beta-agonist (LABA). LABAs have been associated with an increased risk of asthma-related death in some studies, although this risk is debated. Patients with existing cardiovascular conditions should be monitored closely.\n*   **Immunosuppression:** Fluticasone, an inhaled corticosteroid, can cause local immunosuppression in the mouth and throat, leading to an increased risk of oral candidiasis (thrush). Patients should rinse their mouth with water after each use of the inhaler to minimize this risk.\n*   **Pneumonia:** Inhaled corticosteroids may increase the risk of pneumonia, especially in patients with COPD.\n*   **Adrenal Suppression:** While less likely with inhaled corticosteroids than with oral steroids, long-term use can potentially lead to adrenal suppression.\n*   **Bone Density Loss:** Long-term use of inhaled corticosteroids can contribute to bone density loss.\n\n**Important Considerations:**\n\n*   **Social Support:** The patient reports social isolation and limited social contact. Connecting the patient with resources and support services for survivors of intimate partner violence is crucial.\n*   **Mental Health Screening:** Given the history of abuse, regular mental health screening is important.\n\n**Recommendations:**\n\n*   **Assess Medication Adherence:** Inquire about any difficulties the patient may be experiencing in taking their medication as prescribed.\n*   **Counseling and Support:** Provide information about resources for victims of intimate partner violence, including local shelters, support groups, and legal aid.\n*   **Monitor for Side Effects:** Regularly assess the patient for any adverse effects of Fluticasone/Salmeterol, such as oral candidiasis or signs of respiratory infection.\n*   **Mental Health Support:** Offer mental health support and monitor for signs of depression, anxiety, or PTSD.\n*   **Safe Medication Storage:** Discuss safe medication storage practices, considering the patient's living situation.\n*   **Fall Risk:** Review medications and other fall risk factors for the patient.\n\n**Disclaimer:** This information is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 30,
        "patient_id": "b734c85d-0a1e-4d03-8b89-c19d2a6a1157",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Chloride: 103.9 progress for a patient with Prediabetes? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 molfunc_protein 5515.",
        "llm_answer": "I am unable to answer this question. The provided information does not contain details about how Chloride levels might progress in a patient with prediabetes. The knowledge graph triples also do not give information relating chloride levels and prediabetes.\n",
        "rag_answer": "This query cannot be answered using the available information. The patient's chloride level is within normal range (98-106 mmol/L). Furthermore, the knowledge graph does not contain any information about how chloride levels might progress in patients with prediabetes.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 31,
        "patient_id": "e8503522-82ff-67a2-4dad-29281d6318de",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Body Weight: 83.2 progress for a patient with Chronic sinusitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about the relationship between Body Weight: 83.2 and Chronic sinusitis (disorder).\n",
        "rag_answer": "I cannot answer the question about how the symptom Body Weight: 83.2 might progress for a patient with Chronic sinusitis (disorder) based on the provided information. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not contain information about the typical progression of body weight in patients with chronic sinusitis.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 32,
        "patient_id": "323a0bc9-41a7-bd5c-c431-eab5dca111f5",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Not in labor force (finding) taking Acetaminophen 325 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am sorry, but I cannot answer this question, as contraindications are not risks and also the facts provided are not patient-specific.",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains information about drug interactions and contraindications for a drug with ID DB01556, but it does not provide specific risks associated with \"Not in labor force (finding)\" or Acetaminophen 325 MG Oral Tablet.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 33,
        "patient_id": "6c590adb-27ed-cd72-963c-dd6ef39be384",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute bronchitis (disorder) taking Ibuprofen 200 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some risks to consider for a patient with acute bronchitis taking Ibuprofen:\n\n*   **Contraindications:** Ibuprofen has several contraindications. The specific contraindications are listed as codes 5044, 1200\\_1134\\_15512\\_5080\\_100078, and 992. You would need to look up what these codes represent to understand the specific contraindications.\n",
        "rag_answer": "Ibuprofen (DB01556) has several contraindications that should be considered. The provided knowledge graph lists the following: 5044, 1200_1134_15512_5080_100078, and 992. Unfortunately, without more information about what these codes represent, I cannot provide specific details on the risks associated with these contraindications. You should consult with a healthcare professional or pharmacist for a comprehensive review of the risks of taking ibuprofen, especially considering the patient's acute bronchitis and other conditions.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 34,
        "patient_id": "1e7cdf67-1787-d1f1-5dbf-ee25aea4b493",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Chronic sinusitis (disorder) taking Naproxen sodium 220 MG Oral Tablet?",
        "llm_answer": "Based on the patient's profile and medical knowledge, here are some risks to consider for a patient with chronic sinusitis taking Naproxen sodium:\n\n*   **Gastrointestinal Issues:** Naproxen is an NSAID, and NSAIDs can cause stomach upset, ulcers, bleeding, and perforation.\n*   **Cardiovascular Risks:** NSAIDs may increase the risk of heart attack, stroke, and high blood pressure.\n*   **Kidney Problems:** Long-term use of NSAIDs can lead to kidney damage.\n*   **Allergic Reactions:** Some individuals may be allergic to naproxen, resulting in rash, hives, itching, swelling, or difficulty breathing.\n*   **Drug Interactions:** Naproxen can interact with other medications.\n\nGiven the patient's profile, the following are important considerations:\n\n*   The patient has a history of anxiety and stress. NSAIDs can sometimes exacerbate these conditions.\n*   The patient's cholesterol levels are slightly elevated, which, combined with NSAID use, could further increase cardiovascular risk.\n*   The patient is taking other medications, including acetaminophen and amoxicillin/clavulanate. Potential interactions should be evaluated.",
        "rag_answer": "Here are some risks to consider for a patient with chronic sinusitis taking Naproxen Sodium:\n\n*   **Gastrointestinal Issues:** Naproxen, like other NSAIDs, can increase the risk of stomach ulcers, bleeding, and perforation. The risk is higher in older adults and those with a history of ulcers or GI bleeding.\n*   **Cardiovascular Risks:** NSAIDs can increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. This risk may increase with the duration of use. Patients with pre-existing cardiovascular disease may be at greater risk.\n*   **Kidney Problems:** Long-term use of NSAIDs can lead to kidney damage, including acute kidney injury and chronic kidney disease.\n*   **Increased Blood Pressure:** Naproxen can lead to new onset or worsening of pre-existing hypertension.\n*   **Allergic Reactions:** Although less common, Naproxen can cause allergic reactions, including skin rash, hives, and anaphylaxis.\n*   **Interactions with Other Medications:** Naproxen can interact with other medications, such as blood thinners (e.g., warfarin), aspirin, and certain antidepressants.\n*   **Exacerbation of Sinusitis:** In rare cases, NSAIDs can exacerbate respiratory conditions, including sinusitis.\n*   **Fluid Retention and Edema:** NSAIDs can cause fluid retention, which may be a concern for individuals with certain medical conditions.\n*   **Age:** The risk of adverse events from NSAIDs, including Naproxen, increases with age.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 35,
        "patient_id": "d846a69a-fa5a-7d43-c0c5-c4c1ef578f54",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 45.3 progress for a patient with Part-time employment (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The patient's hematocrit level has been recorded at 35.4% and 45.3% at different times. It is difficult to predict how the symptom will progress, and part-time employment is unlikely to have a direct effect. However, the patient's anemia and other conditions could impact hematocrit levels. Monitoring and addressing the underlying cause of the anemia is important.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain any information about how part-time employment might affect hematocrit levels. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 36,
        "patient_id": "5f26a8b2-4d58-59ef-c264-8d189ed7a933",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Which race(s) are you?: White progress for a patient with First degree burn?",
        "llm_answer": "The symptom \"Which race(s) are you?: White\" is not a symptom that can progress or change in relation to a first-degree burn. It is a demographic characteristic. First-degree burns primarily affect the epidermis, the outer layer of skin. The usual symptoms will be pain, redness, and minor swelling. The skin might be sensitive to the touch. Usually, first-degree burns heal within a few days to a week without scarring.\n",
        "rag_answer": "The symptom \"Which race(s) are you?: White\" is not a symptom that can progress. It is a demographic characteristic indicating the patient's race as White. First-degree burns primarily affect the outer layer of skin (epidermis). The typical progression of a first-degree burn involves:\n\n1.  **Initial appearance:** Redness, mild pain, and dry skin.\n2.  **Healing:** The burn usually heals within a week without scarring. The skin may peel as part of the healing process.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 37,
        "patient_id": "d8e88617-b8f0-d89f-b4f0-abdde20c59db",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Stress (finding) taking Galantamine 4 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, the following risks should be considered for a patient with Stress (finding) taking Galantamine 4 MG Oral Tablet (DB01556):\n\n*   **5044**\n*   **1200_1134_15512_5080_100078**\n*   **992**",
        "rag_answer": "Based on the provided information, I can offer some potential risks to consider for a patient with stress taking Galantamine:\n\n*   **Contraindications:** The knowledge graph indicates several contraindications for Galantamine (DB01556), represented by numerical codes. Unfortunately, without knowing what these codes (5044, 1200_1134_15512_5080_100078, 992, etc.) represent, I cannot provide specific details about these contraindications. You would need to consult a medical professional or a database that deciphers these codes to understand the exact nature of these risks.\n*   **Drug-Drug Interactions:** The knowledge graph lists numerous potential drug-drug interactions between Galantamine (DB01556) and other drugs (DB00328, DB00461, etc.). Again, without knowing the names of the drugs represented by these codes, I cannot determine if the patient is taking any of these medications. You would need to check the patient's medication list against a drug interaction database to identify any potential interactions.\n\n**Additional Considerations Based on Patient Profile:**\n\n*   **Stress:** While not a direct contraindication, the patient's stress levels should be monitored.\n*   **Other Conditions and Medications:** A comprehensive review of all the patient's conditions and medications is crucial to identify any potential risks or interactions associated with Galantamine.\n\n**Disclaimer:** I am an AI assistant and cannot provide medical advice. This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 38,
        "patient_id": "2fc1d429-375b-22be-1a5f-f07fa3eaba62",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Drug overdose taking amLODIPine 2.5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "Based on the knowledge graph provided, amLODIPine (DB01556) is contraindicated in the following conditions: 5044, 1200_1134_15512_5080_100078 and 5009. It is also contraindicated in condition 5044. Without knowing what those conditions represent, I cannot provide specific risks for this patient.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph describes drug interactions and contraindications for a drug identified as DB01556. To provide risks specific to amLODIPine for a patient with a history of drug overdose, I would need information about amLODIPine interactions and contraindications.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 39,
        "patient_id": "8702b04b-d1f1-fb3f-7787-dd74b3ddd8c3",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Received higher education (finding) taking Vitamin B 12 5 MG/ML Injectable Solution? Based on the knowledge graph which includes facts such as: 4878 disease_protein 5010; 4878 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 molfunc_protein 5515.",
        "llm_answer": "I am unable to answer this question. The knowledge graph does not contain information about \"Received higher education (finding) taking Vitamin B 12 5 MG/ML Injectable Solution\".\n",
        "rag_answer": "I'm sorry, but the provided knowledge graph does not contain information about the risks associated with \"Received higher education (finding)\" or \"Vitamin B 12 5 MG/ML Injectable Solution\". Therefore, I cannot answer your question.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 40,
        "patient_id": "8dc2f066-f116-0180-277f-d4670b7caa6d",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Familial Alzheimer's disease of early onset (disorder) taking Memantine hydrochloride 2 MG/ML Oral Solution? Based on the knowledge graph which includes facts such as: 1541 drug_effect DB01024; 1541 drug_effect DB01165; 1541 drug_effect DB01137.",
        "llm_answer": "I am unable to answer this question. I do not have the ability to process the knowledge graph provided.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about the risks of Memantine hydrochloride 2 MG/ML Oral Solution (DB00959). The knowledge graph only contains information about contraindications of Memantine (DB00959).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 41,
        "patient_id": "1f3ccd29-4283-4d48-eec4-0b501cb2abfd",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Limited social contact (finding) taking Acetaminophen 325 MG / oxyCODONE Hydrochloride 5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "Based on the patient's profile, here are some risks to consider for a patient with limited social contact taking Acetaminophen/Oxycodone:\n\n*   **Social Isolation and Mental Health:** The patient has \"Limited social contact (finding)\" and \"Social isolation (finding)\", and history of \"Severe anxiety (panic) (finding)\", and GAD-7 scores ranging from 0 to 16. Social isolation can exacerbate mental health conditions like anxiety and depression. Opioids like oxycodone can also have mood-altering effects, and in individuals with pre-existing mental health issues, this could lead to worsening symptoms or increased risk of misuse.\n\n*   **Risk of Opioid Misuse/Dependence:** Given the patient's history of \"Unhealthy alcohol drinking behavior (finding)\" and AUDIT-C scores ranging from 1 to 10, there may be an increased risk of misusing the Acetaminophen/Oxycodone medication. Limited social contact can also be a risk factor for substance misuse as individuals may turn to substances to cope with loneliness or isolation.\n\n*   **Fall Risk:** The patient has multiple fall risk assessments with scores ranging from low to high risk. Oxycodone can cause dizziness and drowsiness, increasing the risk of falls, especially in someone with pre-existing balance issues or risk factors for falls.\n\n*   **Adverse Effects and Monitoring:** Acetaminophen/Oxycodone can cause side effects such as constipation, nausea, and respiratory depression. It is important to monitor the patient for these side effects, especially given their other health conditions and medications.\n\nIt is important to note that this information is not exhaustive and does not substitute for professional medical advice. A healthcare provider should carefully evaluate the patient's individual circumstances and risk factors before prescribing Acetaminophen/Oxycodone.",
        "rag_answer": "Based on the provided information, here are some risks to consider for a patient with limited social contact taking Acetaminophen/oxyCODONE:\n\n*   **Drug Interactions:** Acetaminophen/oxyCODONE has drug-drug interactions with DB00396.\n*   **Contraindications:** Acetaminophen/oxyCODONE is contraindicated with 5015 and 6920.\n*   **Exposure to Disease:** D008628, D002104 and D003634 are exposure to disease with 6920 and 5015.\n*   **Disease association:** 43 and 1621 disease are associated with 956 and 5384 proteins.\n\nIt's important to note that this information is based solely on the provided data. A comprehensive risk assessment should involve a thorough review of the patient's medical history, a physical examination, and potentially further investigation.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 42,
        "patient_id": "71d3115d-9b63-349a-c539-8e46f54d0397",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Social isolation (finding) taking Simvastatin 20 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some risks to consider for a patient with social isolation taking Simvastatin 20 MG Oral Tablet, based on the provided knowledge graph snippet and the patient's profile:\n\n*   **Contraindications:** The knowledge graph mentions Simvastatin (DB01556) has contraindications related to codes 5044, 1200, 1134, 15512, 5080, 100078, and 992. To fully understand these, you would need to look up what these codes represent in a medical coding system (like ICD-10 or SNOMED CT). These could indicate conditions or situations where Simvastatin should not be used.\n",
        "rag_answer": "I cannot answer the question about the risks of taking Simvastatin 20 MG Oral Tablet, since the knowledge graph only contains information about drug interactions and contraindications for a drug with ID DB01556, but not about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 43,
        "patient_id": "d5fcf85c-fbb4-e758-7018-58d168b39a82",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Viral sinusitis (disorder) taking piperacillin 2000 MG / tazobactam 250 MG Injection?",
        "llm_answer": "Based on the patient's profile and the medication piperacillin/tazobactam, here are some risks to consider:\n\n*   **Allergic Reactions:** Piperacillin/tazobactam is a penicillin-derivative antibiotic. Allergic reactions, including rash, hives, itching, and in severe cases, anaphylaxis, are possible.\n*   **Kidney Issues:** The patient has sepsis and ARDS and is on multiple medications including vancomycin and norepinephrine. This increases the risk of kidney injury, and piperacillin/tazobactam can further contribute to this. Kidney function should be monitored.\n*   **Electrolyte Imbalance:** The patient has sepsis and ARDS, which may cause electrolyte imbalances. Piperacillin/tazobactam can sometimes affect electrolyte levels (e.g., sodium, potassium).\n*   **Clostridioides difficile Infection (CDI):** Antibiotics, including piperacillin/tazobactam, can disrupt the normal gut flora, leading to *C. difficile* infection, which causes diarrhea.\n*   **Bleeding Risk:** Piperacillin/tazobactam can sometimes interfere with blood clotting, potentially increasing the risk of bleeding, especially if the patient is on other medications that affect clotting.\n*   **Seizures:** Although rare, piperacillin/tazobactam can increase the risk of seizures, particularly in patients with kidney problems or those receiving high doses.\n*   **Drug Interactions:** Piperacillin/tazobactam can interact with other medications.\n\nBecause the patient is being treated for sepsis and ARDS, this is a complex clinical scenario. The potential benefits of the antibiotic should be weighed against these risks, and the patient should be closely monitored.\n",
        "rag_answer": "Based on the patient's profile and the medication piperacillin/tazobactam, here are the risks to consider:\n\n*   **Sepsis and ARDS:** The patient has diagnoses of sepsis and acute respiratory distress syndrome (ARDS). Antibiotics like piperacillin/tazobactam are often used to treat sepsis, but it's important to monitor for signs of worsening infection or complications related to ARDS.\n\n*   **Kidney Function:** Piperacillin/tazobactam can affect kidney function.\n\n*   **Allergic Reactions:** Allergic reactions are a risk with any antibiotic, including piperacillin/tazobactam.\n\n*   **Clostridioides difficile Infection:** Antibiotics can disrupt the normal gut flora, leading to *Clostridioides difficile* infection.\n\n*   **Drug Interactions:** Review the patient's other medications (acetaminophen, vancomycin, norepinephrine) for potential interactions with piperacillin/tazobactam.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 44,
        "patient_id": "1ded4f39-fa12-544b-0a17-1050427df77b",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Hypertriglyceridemia (disorder) taking PACLitaxel 100 MG Injection? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I am unable to answer your question based on the information provided. I can generate responses from my pre-trained knowledge, but I do not have access to the knowledge graph you mentioned.",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about risks associated with taking PACLitaxel 100 MG Injection while having Hypertriglyceridemia (disorder).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 45,
        "patient_id": "49325aa6-5655-1d1f-5745-46902c91f3b9",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Urea Nitrogen: 17.8 progress for a patient with Alzheimer's disease (disorder)? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 disease_protein 5010.",
        "llm_answer": "Urea Nitrogen: 17.8, in the context of Alzheimer's disease (disorder), doesn't have a directly established progression pattern based on the provided information. While the knowledge graph indicates associations between Alzheimer's and certain proteins, it doesn't offer specific insights into how Urea Nitrogen levels might change over time in individuals with Alzheimer's. To determine the likely progression, it would be best to consult with a healthcare professional who can consider the patient's overall health status and other relevant factors.\n",
        "rag_answer": "Based on the provided information, I cannot determine how Urea Nitrogen levels specifically progress in Alzheimer's disease. The knowledge graph provides associations between a disease (represented by a number, possibly an identifier) and proteins. The patient's symptoms include a Urea Nitrogen level of 17.8. However, there's no direct link established between Alzheimer's and Urea Nitrogen levels or their progression in the provided data. More specific medical knowledge would be needed to answer this question accurately.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 46,
        "patient_id": "ac643af6-1a32-08ce-df40-1c31348bcb41",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Appendicitis taking lisinopril 10 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the information provided, here are the risks to consider for a patient with appendicitis taking lisinopril:\n\n*   **Contraindication 5044:** This suggests a general contraindication that needs further clarification based on what \"5044\" refers to in your knowledge graph.\n*   **Contraindication 1200\\_1134\\_15512\\_5080\\_100078:** This also suggests a specific contraindication involving multiple factors (\"1200\", \"1134\", \"15512\", \"5080\", and \"100078\"). The specifics need to be defined based on the knowledge graph.\n*   **Contraindication 992:** This contraindication also requires further clarification from your knowledge graph to understand what \"992\" represents.\n\nIt's important to note that these contraindications require more context from the knowledge graph to understand their specific implications for this patient. As a medical assistant, I would recommend consulting with the physician or pharmacist to clarify these contraindications and determine the best course of action for the patient.",
        "rag_answer": "Based on the provided information:\n\n*   **Lisinopril (DB01556) Contraindications:** The knowledge graph lists several contraindications for Lisinopril (DB01556), represented by numerical codes. Without knowing what these codes signify, it's impossible to determine the specific risks.\n\nIt is important to consult with a healthcare professional or refer to comprehensive medical databases for detailed information on Lisinopril contraindications and potential risks associated with appendicitis.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 47,
        "patient_id": "f7019a56-1940-b131-f5e2-39439c16a942",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Stress (finding) taking NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "Based on the provided information, here are some risks to consider for a patient with stress taking Albuterol:\n\n*   **Albuterol contraindications**: Based on the knowledge graph, Albuterol (DB00304) has a contraindication with a protein coded by gene 5347. Review the gene and associated risks.\n\nIt's important to note that this information is not exhaustive. Always consult with a healthcare professional for personalized medical advice.\n",
        "rag_answer": "Based on the provided information:\n\n*   **Albuterol (NDA020503)**: From the knowledge graph, DB00153 represents Albuterol.\n*   **Stress (finding)**: Stress is associated with the code 5347.\n\nThe knowledge graph states \"DB00153 contraindication 21187\\_11237\\_11470\" and \"DB00153 contraindication 1336\". However, there is no direct link found in the knowledge graph indicating a contraindication between Albuterol (DB00153) and Stress (5347). Therefore, the risks related to Stress and Albuterol cannot be determined.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 48,
        "patient_id": "322ab10f-3c76-7f32-7581-d96e262518c2",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Received certificate of high school equivalency (finding) taking Acetaminophen 325 MG Oral Tablet?",
        "llm_answer": "I cannot provide specific risk information about taking Acetaminophen 325 MG Oral Tablet for a patient with Received certificate of high school equivalency (finding) .",
        "rag_answer": "I am unable to answer this question. The provided information does not contain any risks associated with Received certificate of high school equivalency (finding) taking Acetaminophen 325 MG Oral Tablet.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 0,
        "patient_id": "7562e458-cfcd-2ab3-f1f7-41665db2af63",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What is your current work situation?: Full-time work progress for a patient with Not in labor force (finding)? Based on the knowledge graph which includes facts such as: 12532 phenotype_protein 6335.",
        "llm_answer": "It's difficult to predict how \"What is your current work situation?: Full-time work\" might progress for a patient with \"Not in labor force (finding)\" as these are not symptoms but rather descriptions of employment status. However, the patient's employment status could change over time. It's possible for someone who is currently employed full-time to later become not in the labor force, and vice versa. These changes can be influenced by various factors, including their health conditions (chronic pain, osteoarthritis), stress levels, social contact, and other socioeconomic factors.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains facts about the relationship between phenotypes and proteins, and does not contain information about the risks associated with taking Naproxen sodium 220 MG Oral Tablet for Acute viral pharyngitis.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 1,
        "patient_id": "4cc043f9-1872-e18b-d387-2eb492f075a7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph does not have the information to answer the question.\n",
        "rag_answer": "I cannot determine how the symptom 'Body Weight: 69.2' might progress specifically for a patient with 'Misuses drugs (finding)' based on the provided knowledge graph. The knowledge graph focuses on protein and disease relationships, drug contraindications, and cellular components, but it does not contain information about how drug misuse directly impacts body weight.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 2,
        "patient_id": "94cecba2-18b0-72a1-334d-427ecbf4fdff",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Anemia (disorder) taking Hydrochlorothiazide 25 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some risks to consider for a patient with anemia taking hydrochlorothiazide, based on the provided information:\n\n*   **Electrolyte Imbalance:** Hydrochlorothiazide can cause electrolyte imbalances, including low potassium (hypokalemia) and low sodium (hyponatremia). Anemia can sometimes be associated with or exacerbated by electrolyte imbalances, so this is an important consideration.\n*   **Kidney Problems:** The contraindication \"1200\\_1134\\_15512\\_5080\\_100078\" may refer to kidney issues. Hydrochlorothiazide can affect kidney function, and this could be particularly relevant in the context of anemia, as kidney problems can sometimes contribute to anemia.\n*   **Other Contraindications**: The codes \"5044\" and \"992\" likely refer to specific contraindications that are not fully elaborated on in this context. To fully understand the risks, these codes would need to be cross-referenced with a medical database or knowledge base to determine the specific contraindications they represent.",
        "rag_answer": "I cannot predict how the symptom \"Pain severity - 0-10 verbal numeric rating [Score] - Reported: 3.0\" might progress for this patient, nor can I use the provided knowledge graph to do so. The knowledge graph contains drug-related information (contraindications and drug-drug interactions for a drug with ID DB01556) and is not related to pain progression or the impact of education level on pain.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 3,
        "patient_id": "15e34bee-9f5e-e034-3e49-1406647f3b4d",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What is your housing situation today?: I choose not to answer this question progress for a patient with Appendicitis? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "I am unable to answer this question. \"What is your housing situation today?: I choose not to answer this question\" is a social determinant of health, not a symptom, and the given information does not contain any facts about Appendicitis.\n",
        "rag_answer": "I am unable to answer this question. The patient's profile does include Alcoholism and Triglycerides level. However, I do not have the ability to predict how Triglycerides level might progress.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 4,
        "patient_id": "d31efc1d-0594-002a-61f2-4eee3a4c8cec",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Full-time employment (finding) taking 4 ML norepinephrine 1 MG/ML Injection? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the provided information, I cannot directly determine specific risks associated with full-time employment and norepinephrine injection (4 ML norepinephrine 1 MG/ML Injection). I can only tell you that Norepinephrine is contraindicated in the following cases:\n*   5044\n*   1200, 1134, 15512, 5080, 100078\n*   992\n\nTo determine specific risks of full-time employment while taking Norepinephrine, a medical professional would need to evaluate the patient's specific job duties, potential interactions with the medication, and the patient's overall health status.\n",
        "rag_answer": "I am sorry, I cannot answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556) and does not include information about the progression of Urea Nitrogen levels in relation to stress.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 5,
        "patient_id": "ed1f5200-78a5-de4b-0c49-bf64c98ecae8",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Pain severity - Reported: 7.4 progress for a patient with Victim of intimate partner abuse (finding)?",
        "llm_answer": "Intimate partner abuse is associated with increased pain severity, and this patient has reported a pain severity of 7.4. Without additional information, I cannot predict how the pain might progress, but I can offer some general information. It is likely that the pain may persist or worsen if the abuse continues. It may also lead to chronic pain conditions.\n",
        "rag_answer": "I am unable to predict how the symptom \"What address do you live at?: 790 Hamill Promenade\" might progress, as it is not a symptom but rather an address. I can answer questions about symptoms related to Viral sinusitis (disorder), if you have any.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 6,
        "patient_id": "5c68d61d-ff44-a6f2-fabd-1cf309196a1d",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom How often do you see or talk to people that you care about and feel close to (For example: talking to friends on the phone  visiting friends or family  going to church or club meetings)?: 3 to 5 times a week progress for a patient with Unemployed (finding)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "Based on the provided information, here's how the symptom \"How often do you see or talk to people that you care about and feel close to (For example: talking to friends on the phone visiting friends or family going to church or club meetings): 3 to 5 times a week\" might progress for a patient with \"Unemployed (finding)\":\n\n**Possible Progression:**\n\n*   **Decreased Social Interaction:** Unemployment can lead to social isolation due to factors like decreased self-esteem, financial constraints limiting social activities, and the stress of job searching. The patient may start seeing loved ones less frequently.\n\n**Factors Influencing Progression:**\n\n*   **Stress:** The patient is experiencing a lot of stress.\n*   **Social Isolation:** The patient is experiencing social isolation.\n*   **Intimate Partner Abuse:** The patient is a victim of intimate partner abuse.\n*   **Financial Strain:** The patient reported that in the past year  have you or any family members you live with been unable to get any of the following when it was really needed?: Childcare, Food, Phone, Utilities.\n",
        "rag_answer": "I cannot predict how the symptom \"Chloride: 102.0\" might progress specifically for a patient with stress based on the provided information. The knowledge graph includes facts about diseases, proteins, and biological processes, but it doesn't contain information about the direct relationship between stress and chloride levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 7,
        "patient_id": "6666bcfc-4f47-9993-ddfe-2691afdc4696",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]: 3.0 progress for a patient with Limited social contact (finding)?",
        "llm_answer": "Generalized anxiety disorder (GAD) and limited social contact can significantly influence each other. Here's how the GAD-7 score might progress in a patient with limited social contact:\n\n*   **Worsening Anxiety:** Social isolation is a known risk factor for mental health issues, including anxiety. Limited social contact can lead to increased feelings of loneliness, isolation, and a lack of support, potentially causing the GAD-7 score to increase over time.\n*   **Feedback Loop:** Anxiety itself can make it more difficult for someone to initiate or maintain social contact. The patient may avoid social situations due to fear of judgment, embarrassment, or triggering anxiety symptoms, further exacerbating their social isolation. This can create a negative feedback loop where anxiety and isolation reinforce each other, leading to a progressively higher GAD-7 score.\n*   **Impact on Coping Mechanisms:** Social interaction often provides opportunities for coping with stress and anxiety through sharing experiences, seeking advice, or simply feeling understood. With limited social contact, the patient may have fewer healthy coping mechanisms available, potentially leading to an increase in anxiety symptoms and a higher GAD-7 score.\n*   **Potential for Improvement:** If the patient actively seeks help for their anxiety and begins to address their social isolation (e.g., through therapy, support groups, or engaging in social activities), the GAD-7 score could decrease over time as their anxiety improves and they develop a stronger social support system.\n*   **Fluctuations:** The GAD-7 score may not be consistently progressive. It could fluctuate depending on various factors such as life events, stress levels, and the availability of support. However, without intervention, the overall trend might be towards worsening anxiety due to the compounding effects of social isolation.\n",
        "rag_answer": "Here are some risks to consider for a patient with acute bacterial sinusitis taking Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]:\n\n*   **Respiratory Depression:** Oxycodone can cause significant respiratory depression, especially in individuals with pre-existing respiratory conditions like pulmonary emphysema. This risk is heightened when combined with other medications that depress the central nervous system.\n*   **Addiction and Abuse Potential:** Oxycodone is an opioid with a high potential for abuse and addiction. Patients with a history of substance abuse or those with risk factors such as \"Has a criminal record (finding)\" or \"Reports of violence in the environment (finding)\" may be at higher risk. The \"Abuse-Deterrent\" formulation aims to reduce this risk, but does not eliminate it.\n*   **Central Nervous System (CNS) Depression:** Oxycodone can cause drowsiness, dizziness, and impaired cognitive function. This can be exacerbated by other CNS depressants.\n*   **Gastrointestinal Effects:** Opioids like oxycodone can cause constipation, nausea, and vomiting.\n*   **Interactions:** Oxycodone can interact with other medications, potentially increasing the risk of side effects or reducing the effectiveness of either medication.\n*   **Risk of Overdose:** Overdose can occur, leading to respiratory depression, coma, and death.\n*   **Tolerance and Dependence:** With prolonged use, tolerance to oxycodone can develop, requiring higher doses to achieve the same level of pain relief. Physical dependence can also occur, leading to withdrawal symptoms if the medication is abruptly discontinued.\n*   **Withdrawal Symptoms:** Abrupt cessation of oxycodone can lead to withdrawal symptoms such as restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, and goosebumps.\n*   **Intimate Partner Abuse:** Given the patient's history of being a victim of intimate partner abuse, it's important to consider whether the medication could be misused by an abuser or if access to the medication could create a dangerous situation.\n*   **Mental Health:** The patient also reports stress, which could potentially be worsened by opioid use due to its impact on mood and cognitive function.\n\nGiven the patient's history, a non-opioid pain reliever might be a better choice.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 8,
        "patient_id": "b8f0f7fa-c623-67e2-6434-d1ddb63de9df",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Chronic low back pain (finding) taking Amlodipine 5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I am unable to answer this question because the provided knowledge graph has no information related to the risks associated with Chronic low back pain and taking Amlodipine.",
        "rag_answer": "I cannot predict how Systolic Blood Pressure might progress in a patient with Myocardial Infarction based on the provided knowledge graph. The provided facts relate to protein pathways and drug interactions/contraindications of Nitroglycerin, which are not directly related to predicting the progression of systolic blood pressure in myocardial infarction.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 9,
        "patient_id": "6ad59647-a0db-2a01-dca6-087b48bfb805",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Albumin [Mass/volume] in Serum or Plasma: 5.5 progress for a patient with Stress (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The information you provided does not include any information about how \"Albumin [Mass/volume] in Serum or Plasma: 5.5\" might progress for a patient with Stress (finding) in the knowledge graph.",
        "rag_answer": "Based on the provided information, I can offer some potential considerations:\n\n*   **Lisinopril Contraindications:** The knowledge graph indicates several contraindications for lisinopril (DB01556), represented by numerical codes. Without knowing what these codes stand for, it's difficult to provide specific details. Generally, contraindications are conditions or situations where a drug should not be used.\n\nIt's important to consult with the patient's oncologist and/or primary care physician for a comprehensive risk assessment. They can consider the patient's full medical history, current health status, and potential interactions with other medications or treatments.",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 10,
        "patient_id": "4d3204cc-fbbe-77ba-8a8c-ea49d0422d33",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Heart rate: 65.0 progress for a patient with Victim of intimate partner abuse (finding)?",
        "llm_answer": "The heart rate of 65.0 could be affected by the patient's experience as a victim of intimate partner abuse. This abuse can cause significant stress and anxiety, which could lead to fluctuations in heart rate. While a heart rate of 65.0 falls within the normal range, the patient's history of abuse suggests that their heart rate could increase during times of stress or fear related to their experiences. It's important to monitor the patient's heart rate over time to identify any patterns or changes that may be related to their abuse.\n",
        "rag_answer": "The patient's total cholesterol is 192.3 mg/dL. The progression of this symptom in a patient with limited social contact is difficult to predict with certainty, as it depends on various factors, including diet, exercise, genetics, and other underlying health conditions. However, limited social contact can contribute to poorer health outcomes in several ways. It may be associated with unhealthy lifestyle choices, such as poor diet and lack of exercise, which can negatively impact cholesterol levels. Social isolation can also lead to increased stress and depression, which may also affect cholesterol levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 11,
        "patient_id": "233e8b42-45d4-726a-65c9-2490d752beda",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Viral sinusitis (disorder) taking Acetaminophen 325 MG / Oxycodone Hydrochloride 10 MG Oral Tablet [Percocet]? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some potential risks to consider for a patient with viral sinusitis taking Acetaminophen/Oxycodone (Percocet), based on the provided information and common medical knowledge:\n\n*   **Contraindications:** The knowledge graph mentions contraindications related to \"DB01556\" which is the DrugBank ID for Acetaminophen/Oxycodone. The numbers following \"contraindication\" likely refer to specific contraindications within a medical coding system (such as ICD or SNOMED). Without knowing the specific conditions these codes represent, it's difficult to provide precise details. However, contraindications are reasons why a medication should *not* be used. You should consult the coding system to determine what conditions these codes map to and how that relates to the patient.\n\nIt's important to note that the information provided is limited. A full risk assessment would require a complete medical history, physical examination, and potentially further investigations. Please consult with a qualified healthcare professional for personalized medical advice.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not provide information about the relationship between educational attainment and stress levels.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 12,
        "patient_id": "9e83f507-cebb-a7e5-5a9b-aea2d6d2c8f4",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Leukocytes [#/volume] in Blood by Automated count: 3.7 progress for a patient with Osteoporosis (disorder)? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5098; DB00304 contraindication 11057; DB00304 contraindication 20671.",
        "llm_answer": "Based on the information available, I cannot determine how Leukocytes [#/volume] in Blood by Automated count: 3.7 might progress specifically for a patient with Osteoporosis. The patient profile does include the symptom Leukocytes [#/volume] in Blood by Automated count: 3.7, the condition Osteoporosis (disorder) and a list of medications. Additionally, the knowledge graph includes facts \"DB00304 contraindication 5098; DB00304 contraindication 11057; DB00304 contraindication 20671.\" which does not relate to the progression of Leukocytes in a patient with Osteoporosis.\n",
        "rag_answer": "Some risks to consider for a patient taking Verapamil Hydrochloride 40 MG (DB00304) include contraindications related to the conditions 5098, 11057, and 20671. Please consult with a healthcare professional for a complete list of risks and contraindications.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 13,
        "patient_id": "3a39b848-0e35-b237-2813-dc81be049590",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Platelet mean volume [Entitic volume] in Blood by Automated count: 12.3 progress for a patient with Part-time employment (finding)?",
        "llm_answer": "Based on the patient's profile, the Platelet mean volume [Entitic volume] in Blood by Automated count is 10.8 and 12.3.\nI am unable to assess how Platelet mean volume [Entitic volume] in Blood by Automated count might progress for a patient with Part-time employment (finding).",
        "rag_answer": "I am unable to predict how the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 might progress for a patient with Received certificate of high school equivalency (finding).",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 14,
        "patient_id": "753bd740-7680-1035-0692-edaf6d545dbe",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Stress (finding) taking Captopril 25 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5010; DB00304 contraindication 5068; DB00304 contraindication 6652_3678_1090_3672_3673_3676_3677_3679_6803.",
        "llm_answer": "Based on the information provided, I can offer some potential risks associated with Stress (finding) and taking Captopril. However, please note that I am an AI and this is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for personalized guidance.\n\nCaptopril Risks:\n\n*   **Contraindications:** The knowledge graph indicates several contraindications for Captopril (DB00304), referencing codes 5010, 5068, and a combined code 6652\\_3678\\_1090\\_3672\\_3673\\_3676\\_3677\\_3679\\_6803. Without specific definitions for these codes, it's difficult to determine the exact nature of these contraindications. *It is crucial to consult a medical professional or a drug database to decode these specific contraindications.*\n\nStress Considerations:\n\n*   **Impact on Blood Pressure:** Stress can significantly impact blood pressure. As Captopril is used to manage blood pressure, it's important to monitor blood pressure regularly, especially when stress levels fluctuate. The effectiveness of Captopril might be influenced by the patient's stress levels.\n*   **Mental Health:** The patient's profile indicates several mental health concerns, including reports of stress and elevated scores in PHQ-9 and GAD-7. These factors could influence adherence to medication and overall treatment outcomes.\n* **Lifestyle Factors**: The patient reports several issues that are likely linked to stress, such as concerns about housing, violence in the environment, intimate partner abuse, and limited social contact. These can have implications for their health and adherence to treatment.\n\nIt is important to consider both the direct pharmacological risks of Captopril and how stress may influence the patient's overall health and response to treatment.\n",
        "rag_answer": "I am unable to answer this question. The provided medical knowledge does not contain information about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": false
    },
    {
        "question_id": 15,
        "patient_id": "541118ce-e381-8922-83b7-3547e3f30076",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Atopic dermatitis taking amLODIPine 2.5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, the following contraindications should be considered for a patient taking amLODIPine 2.5 MG Oral Tablet (DB01556):\n- 5044\n- 1200_1134_15512_5080_100078\n- 992\n\nIt is important to note that this information is limited and a healthcare professional should be consulted for a comprehensive risk assessment. Additionally, atopic dermatitis is not listed as a contraindication for amLODIPine.\n",
        "rag_answer": "Lisinopril (DB01556) is contraindicated (contraindication) in pregnancy (5044, 1200_1134_15512_5080_100078, 992). Therefore, Lisinopril should not be used during normal pregnancy.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 16,
        "patient_id": "90e6fe32-d67b-96cc-bbd6-94aa94d0b20c",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom High Density Lipoprotein Cholesterol: 62.7 progress for a patient with Has a criminal record (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided information does not include details about the relationship between having a criminal record and High Density Lipoprotein Cholesterol levels.\n",
        "rag_answer": "Based on the provided information, the knowledge graph indicates that amLODIPine (DB01556) has several contraindications (5044, 1200_1134_15512_5080_100078, 992, etc.) and drug-drug interactions. However, none of the listed contraindications specifically mention social isolation. It's crucial to consult a comprehensive medical reference or a healthcare professional to determine the specific risks associated with amLODIPine in patients with social isolation. Social isolation itself might influence medication adherence or the patient's ability to recognize and report adverse effects, which should be considered.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 17,
        "patient_id": "5f5de9db-8676-bafc-06d3-cc24416c72b4",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Chronic neck pain (finding) taking 1 ML Epinephrine 1 MG/ML Injection? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph snippets provided, here are some risks to consider for a patient with chronic neck pain taking Epinephrine:\n\n*   **DB01556 contraindication 5044:** This indicates a general contraindication related to the specific code 5044. I cannot specify the exact nature of this contraindication without more information.\n*   **DB01556 contraindication 1200_1134_15512_5080_100078:** This indicates a contraindication related to a combination of codes. I cannot specify the exact nature of this contraindication without more information.\n*   **DB01556 contraindication 992:** This indicates a general contraindication related to the specific code 992. I cannot specify the exact nature of this contraindication without more information.\n\nIt's important to note that without knowing what conditions or medications these codes refer to, I cannot provide a specific risk assessment. A doctor should be consulted.\n",
        "rag_answer": "The symptom \"In the past year have you spent more than 2 nights in a row in a jail prison detention center or juvenile correctional facility?: No\" does not directly relate to the progress of Acute Bronchitis. It's a social history question that could be relevant to overall health and well-being but wouldn't typically be used to assess the progress of bronchitis treatment. The provided medical knowledge graph also does not contain information related to acute bronchitis or incarceration.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 18,
        "patient_id": "dc66d338-11bd-8ca6-d020-7b0bc2acf8a1",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Heart rate: 63.0 progress for a patient with Risk activity involvement (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question with the information provided. The provided knowledge graph only includes drug contraindications, and does not include the symptom progression of heart rate given risk activity involvement.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph includes information about drug interactions and contraindications for a drug with ID DB01556. To provide an answer, the drug ID for Acetaminophen 325 MG Oral Tablet is needed.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 19,
        "patient_id": "b9f5b378-f8cb-7c98-b8e9-0dee64335112",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom MCHC [Mass/volume] by Automated count: 35.7 progress for a patient with Social isolation (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided information does not include any information about the symptom MCHC [Mass/volume] by Automated count: 35.7 or how it might progress for a patient with Social isolation (finding).\n",
        "rag_answer": "Based on the provided information:\n\n*   **Camila 28 Day Pack** contains norethindrone, which has DrugBank ID DB01556.\n*   The knowledge graph (PrimeKG) lists several contraindications for DB01556 (norethindrone), including \"5044\", \"1200\\_1134\\_15512\\_5080\\_100078\", and \"992\". However, the specific conditions these codes represent are not defined in the given context.\n\nGiven the patient's profile, the most relevant risk to consider is the **Tubal pregnancy**. Ectopic pregnancy is a contraindication for DB01556.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 20,
        "patient_id": "2e313061-dc85-c9a1-2442-d29aa9fc4798",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Part-time employment (finding) taking lisinopril 20 MG Oral Tablet?",
        "llm_answer": "Here are some considerations for a patient with part-time employment taking lisinopril:\n\n*   **Hypotension:** Lisinopril can cause a drop in blood pressure, which may lead to dizziness or lightheadedness. This could be a safety concern if the patient's part-time job involves tasks that require alertness or physical coordination.\n*   **Financial strain:** Part-time employment may indicate limited financial resources. The patient's ability to afford lisinopril and other necessary medications should be considered, as medication non-adherence can lead to complications.\n*   **Kidney function:** Lisinopril can affect kidney function. If the patient has impaired kidney function, even mild impairment, it could be exacerbated by lisinopril.\n*   **Social factors:** Part-time employment might influence social interactions and stress levels, which, in turn, can affect overall health and adherence to treatment plans. The presence of 'Limited social contact (finding)' and 'Social isolation (finding)' might indicate psychosocial factors that need to be addressed for better health management.\n*   **Anemia:** This patient has a history of anemia, and lisinopril can sometimes impact red blood cell production. It's important to monitor hemoglobin levels.\n*   **Heart Failure:** Lisinopril is used to manage heart failure. It is important to monitor for symptoms like dyspnea, orthopnea and edema. The use of furosemide along with lisinopril increases the risk of hypotension.\n\nIt's important to note that this is not an exhaustive list, and individual patient factors can influence the specific risks associated with lisinopril. The healthcare provider should always evaluate the patient's overall health status and social determinants of health when prescribing and managing medications.",
        "rag_answer": "Here are some risks to consider for a patient with shock taking losartan potassium:\n\n*   **Hypotension:** Losartan can lower blood pressure. In a patient with shock, who may already have low blood pressure, losartan could exacerbate this, leading to further compromise of vital organ perfusion.\n*   **Hyperkalemia:** Losartan can increase potassium levels. Shock can sometimes be associated with kidney dysfunction, which can also lead to increased potassium. The combination can result in dangerous hyperkalemia.\n*   **Acute Kidney Injury:** Because losartan affects blood pressure and kidney function, it could worsen kidney injury in the setting of shock.\n*   **Drug Interactions:** Losartan can interact with other medications that might be used in the treatment of shock, potentially leading to unpredictable effects.\n\nIt is important to note that the decision to administer losartan to a patient in shock should be made carefully, considering the potential risks and benefits, and with close monitoring of the patient's blood pressure, kidney function, and potassium levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 21,
        "patient_id": "7423e440-7a9a-7bd7-63bd-9da82a500912",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Fall risk total [Morse Fall Scale]: 112.0 progress for a patient with Osteoarthritis of knee? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the patient's profile and the provided information, a Fall risk total [Morse Fall Scale] of 112.0 indicates a very high fall risk. Given the patient's osteoarthritis of the knee, this symptom is likely to progress and be exacerbated by:\n\n*   **Pain and Limited Mobility:** Osteoarthritis causes pain, stiffness, and reduced range of motion in the knee. This can directly impair balance and gait, increasing the likelihood of falls.\n*   **Muscle Weakness:** Osteoarthritis can lead to weakness in the muscles surrounding the knee (e.g., quadriceps, hamstrings). Weak muscles provide less support and stability, further contributing to fall risk.\n*   **Impaired Proprioception:** Osteoarthritis can affect proprioception (the sense of body position and movement in space). This can make it difficult to maintain balance, especially on uneven surfaces or during quick movements.\n*   **Medications:** While not directly related to osteoarthritis, some of the patient's medications (e.g., Meperidine) can cause dizziness or drowsiness, which can also increase fall risk.\n*   **Age:** As people age, their risk of falling increases due to a variety of factors, including decreased muscle strength, impaired balance, and slower reflexes. Osteoarthritis can exacerbate these age-related changes, further increasing fall risk.\n\n**Progression:**\n\nWithout intervention, the patient's high fall risk is likely to persist or worsen. The pain and functional limitations from osteoarthritis may gradually increase, leading to further declines in mobility, balance, and muscle strength. The patient's history of stroke could also impact fall risk due to mobility and balance related issues. Social isolation could affect the patients balance due to lower activity levels.\n\n**Recommendations:**\n\nTo mitigate this, consider the following:\n\n*   **Physical Therapy:** Physical therapy can help improve muscle strength, range of motion, balance, and gait.\n*   **Assistive Devices:** The use of a cane or walker can provide additional support and stability.\n*   **Fall Prevention Strategies:** Implement fall prevention strategies at home, such as removing tripping hazards, improving lighting, and installing grab bars in the bathroom.\n*   **Medication Review:** Review the patient's medications to identify any that may be contributing to fall risk.\n*   **Pain Management:** Effective pain management can improve mobility and reduce the risk of falls.\n*   **Regular Exercise:** Encourage regular weight-bearing and balance exercises to maintain muscle strength and balance.\n*   **Home Safety Assessment:** Conduct a home safety assessment to identify and address potential fall hazards.\n*   **Social Support:** Encourage social engagement to maintain activity levels.\n*   **Address Victim of intimate partner abuse:** Intimate partner violence can be a risk factor for falls.\n\n",
        "rag_answer": "I am unable to answer the question. The patient's profile includes 'Received certificate of high school equivalency (finding)' which is not relevant in this context. The question is asking about risks associated with taking Naproxen, and there is no DrugBank ID that matches 'Naproxen sodium 220 MG Oral Tablet' in the knowledge graph.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 22,
        "patient_id": "fc88755b-6767-bfb6-aa78-584a66b8a139",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Platelets [#/volume] in Blood by Automated count: 213.6 progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: 3784 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4635 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 disease_protein 5010.",
        "llm_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about how Only received primary school education (finding) affects Platelets [#/volume] in Blood by Automated count. The knowledge graph only contains information about the relationships between diseases and proteins.\n",
        "rag_answer": "I can not answer this question. The provided knowledge graph does not contain information about risks associated with Digoxin or part-time employment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 23,
        "patient_id": "f20df06a-4d56-c80d-95c2-a548c65407f7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Heart rate: 98.0 progress for a patient with Body mass index 30+ - obesity (finding)? Based on the knowledge graph which includes facts such as: 10898 disease_protein 5649; 995 disease_protein 5090_13498_8414_10897_33312_10943_11552_14092_12054_11960_11280_11294_11295_11298_11307_11498_12879_13089_13506; 995 cellcomp_protein 5737.",
        "llm_answer": "I am unable to predict the progression of the patient's heart rate based on the information provided and the knowledge graph. The provided data does not contain information on how heart rate might progress in a patient with obesity. The knowledge graph contains facts about disease-protein and cell component-protein relationships, but this is not relevant to the patient's heart rate.\n",
        "rag_answer": "Based on the patient's profile, their pain severity has been reported at different times as 2.0, 3.0, 1.0 and 4.0. I am unable to predict the future progression of the symptom.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 24,
        "patient_id": "9908c417-0d2f-3873-face-1036e1de4ca0",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Laceration of hand taking Naproxen sodium 220 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 1265.",
        "llm_answer": "Here are some risks to consider for a patient with a laceration of the hand taking Naproxen (Naproxen sodium 220 MG Oral Tablet), based on the provided information:\n\n*   **Contraindications:** The knowledge graph mentions that Naproxen (DB01556) has several contraindications (5044, 1200\\_1134\\_15512\\_5080\\_100078, 1265). Since the specifics of these contraindications aren't provided, it's important to consult the full prescribing information to understand what conditions or situations would make Naproxen inappropriate for this patient.\n\nIt's important to note:\n\n*   **This information is not exhaustive.** A full medical evaluation is necessary to determine all potential risks and benefits of Naproxen in this specific patient.\n*   **Always consult with a healthcare professional** for medical advice and treatment decisions.",
        "rag_answer": "I am sorry, I cannot answer this question. The provided information does not include details on how \"Risk activity involvement (finding)\" might affect the progression of the symptom \"DALY: 46.0\". The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), which is not directly relevant to the question about symptom progression in relation to risk activity involvement.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 25,
        "patient_id": "7d4b6d95-1852-4e50-06f6-3af6262505f6",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Victim of intimate partner abuse (finding) taking Acetaminophen 325 MG Oral Tablet [Tylenol]? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "Based on the information provided, I cannot determine the specific risks associated with a patient who is a victim of intimate partner abuse taking Acetaminophen 325 MG Oral Tablet [Tylenol]. I do see that DB00304 (Acetaminophen) has contraindications related to the condition 5347, but I do not have enough information to determine what that contraindication is. Therefore, I recommend consulting with a healthcare professional about the potential risks. They can assess the patient's individual circumstances and provide appropriate guidance.\n",
        "rag_answer": "Based on the information provided, I cannot directly assess the risks of taking Acetaminophen for a second-degree burn. However, I can provide some general considerations:\n\n*   **Acetaminophen (Tylenol)**: This is a common pain reliever and fever reducer.\n*   **Second-degree burn**: This type of burn involves damage to the epidermis and part of the dermis. Pain management is often a key part of treatment.\n\n**Important Considerations:**\n\n*   **Liver Toxicity:** Acetaminophen can cause liver damage, especially at high doses or in individuals with pre-existing liver conditions.\n\n**Given the limitations of the provided information, it's essential to consult with a healthcare professional for personalized medical advice.** They can assess the patient's specific situation, including the severity of the burn, other medical conditions, and current medications, to determine the most appropriate and safe pain management strategy.\n",
        "base_correct": true,
        "rag_correct": false
    },
    {
        "question_id": 26,
        "patient_id": "43a3e92e-50b8-1c12-6381-c4d240fe8fa7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Calcium: 10.0 progress for a patient with Part-time employment (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph does not contain the information required to answer the question.\n",
        "rag_answer": "I cannot answer this question. The provided knowledge graph contains drug interactions and contraindications for a specific drug (Meperidine Hydrochloride, DB01556). It does not contain any information about the progression of calcium levels in patients with limited social contact.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 27,
        "patient_id": "90fda2aa-a5e8-ad7c-f2f7-ecc2bb687514",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Stress (finding) taking Naproxen sodium 220 MG Oral Tablet?",
        "llm_answer": "Here are some risks to consider for a patient with stress taking Naproxen:\n\n*   **Gastrointestinal Issues:** Naproxen, like other NSAIDs, can increase the risk of stomach ulcers, bleeding, and perforation. Stress can exacerbate these risks.\n*   **Cardiovascular Risks:** NSAIDs may increase the risk of serious cardiovascular events, such as heart attack or stroke, especially with long-term use.\n*   **Kidney Problems:** Naproxen can impair kidney function, particularly in individuals with pre-existing kidney issues or those taking other medications that affect the kidneys.\n*   **Drug Interactions:** Naproxen can interact with other medications, such as blood thinners, aspirin, and certain antidepressants, potentially increasing the risk of bleeding or other side effects.\n*   **Fluid Retention and Edema:** NSAIDs can cause fluid retention, which might be a concern for individuals with heart failure or high blood pressure.\n*   **Exacerbation of Stress Symptoms:** While Naproxen addresses physical pain, it doesn't address the underlying cause of stress. In some cases, the side effects of the medication might contribute to increased anxiety or discomfort, indirectly worsening the patient's perception of stress.\n*   **Allergic Reactions:** Although less common, some individuals may experience allergic reactions to Naproxen, ranging from mild skin rashes to severe anaphylaxis.",
        "rag_answer": "Here are some risks to consider for a patient with stress taking Ibuprofen:\n\n*   **Gastrointestinal Issues:** Ibuprofen can increase the risk of stomach ulcers, bleeding, and other gastrointestinal problems. Stress can also exacerbate these issues.\n*   **Cardiovascular Risks:** Ibuprofen, especially at high doses, may increase the risk of heart attack or stroke.\n*   **Kidney Problems:** Long-term use of ibuprofen can lead to kidney damage.\n*   **Drug Interactions:** Ibuprofen can interact with other medications, potentially increasing the risk of side effects.\n*   **Increased Stress Levels:** While ibuprofen can help manage pain and inflammation, it does not address the underlying cause of stress. Relying solely on medication may prevent the patient from seeking more effective stress management strategies.\n*   **Mental Health:** Stress can affect mental health, and some pain relievers can have mood-altering side effects or interact with medications used to treat mental health conditions.\n*   **Addiction:** Prolonged use of pain relievers can lead to dependence and addiction.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 28,
        "patient_id": "8ede6eac-1785-055f-411b-43a507a69f78",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Polyp of colon taking amLODIPine 2.5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer your question. The provided information does not include risks associated with amLODIPine 2.5 MG Oral Tablet or Polyp of colon.\n",
        "rag_answer": "I cannot directly answer how \"Fall risk level [Morse Fall Scale]: Low Risk (MFS Score 0 - 24)\" might progress specifically for a patient with \"Acute viral pharyngitis (disorder)\" as the provided knowledge graph does not contain information relating to fall risk or acute viral pharyngitis. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 29,
        "patient_id": "8d94532e-87ce-486d-adfc-bfa423b11dd2",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom In the past year  have you or any family members you live with been unable to get any of the following when it was really needed?: Food progress for a patient with Full-time employment (finding)?",
        "llm_answer": "Okay, let's analyze how food insecurity might interact with a patient who is currently in full-time employment, considering the other factors in their profile.\n\n**Understanding the Context**\n\n*   **Full-time employment:** This suggests a stable income source, but it doesn't guarantee sufficient income to cover all needs.\n*   **Food insecurity:** The patient reports that in the past year, they or their family members have been unable to get food when needed. This is a significant indicator of potential financial strain, even with full-time employment.\n*   **Family Size:** The patient lives with 7 family members. This large household size will increase the strain on resources, including food.\n*   **Income:** The patient reports an income of $52,606. With 7 family members, this income may not be sufficient to cover all of the family's needs.\n*   **Other Factors:**\n    *   **Social Isolation/Limited Social Contact:** The patient reports seeing or talking to people they care about and feel close to 3 to 5 times a week, which could indicate some level of social support, but it's important to consider the quality of that support.\n    *   **Stress:** The patient reports experiencing \"quite a bit\" of stress, which can be exacerbated by food insecurity.\n    *   **Medicare:** Indicates the patient is likely over 65 or has a qualifying disability.\n\n**Potential Progress and Considerations**\n\nHere's how we might expect the symptom of food insecurity to progress and what to consider:\n\n*   **Continued Food Insecurity Despite Employment:** Even with full-time employment, the patient's income might not be enough to consistently afford sufficient food for a large family.\n    *   *Possible Progress:* The situation could remain the same, worsen if costs increase, or improve if the patient finds additional income sources or receives food assistance.\n*   **Impact on Health and Well-being:** Food insecurity can negatively affect physical and mental health, increasing stress, anxiety, and potentially exacerbating existing conditions. It can also lead to poor nutrition, affecting energy levels and overall health.\n    *   *Possible Progress:* If food security improves, the patient might experience reduced stress, improved energy levels, and better overall health.\n*   **Seeking Assistance:** The patient may need to seek assistance from food banks, government programs (like SNAP), or other community resources to address food insecurity.\n    *   *Possible Progress:* Successful access to and utilization of these resources could significantly improve food security.\n*   **Employment Changes:** A loss of employment or a reduction in hours could worsen food insecurity. Conversely, a promotion or a higher-paying job could improve the situation.\n    *   *Possible Progress:* Job changes can have a significant impact, either positively or negatively.\n*   **Impact on Chronic Conditions:** Food insecurity may make it more difficult to manage chronic conditions like pulmonary emphysema and malignant neoplasm of breast.\n*    **Social Support:** The level of social support the patient receives can affect their ability to cope with food insecurity.\n\n**Recommendations**\n\nGiven this complex situation, here are some recommendations:\n\n*   **Further Assessment:** Conduct a more in-depth assessment of the patient's financial situation, including all income sources, expenses, and debts. A referral to a social worker or case manager may be beneficial.\n*   **Food Assistance Resources:** Provide the patient with information about local food banks, pantries, and government assistance programs (SNAP, WIC, etc.). Help them navigate the application process if needed.\n*   **Nutritional Counseling:** Offer nutritional counseling to help the patient make the most of their food resources and prioritize healthy eating habits.\n*   **Stress Management:** Provide resources and support for stress management, as food insecurity can significantly contribute to stress levels.\n*   **Monitor Health Outcomes:** Closely monitor the patient's physical and mental health for any signs of decline related to food insecurity.\n*   **Evaluate Employment Stability:** Assess the stability of the patient's employment and explore opportunities for job training or career advancement if appropriate.\n\n**In summary,** While the patient has full-time employment, the presence of food insecurity, a large family, and other stressors suggests a need for a comprehensive assessment and intervention to ensure their basic needs are met and their health and well-being are protected.",
        "rag_answer": "Okay, based on the patient's profile and the medication they are taking, here's a breakdown of the risks to consider:\n\n**Risks Related to Intimate Partner Abuse and Medication**\n\n*   **Medication Adherence:** Intimate partner abuse can significantly impact a patient's ability to adhere to their medication regimen. Stress, fear, and control by the abuser can all interfere with taking medication as prescribed. This is especially concerning for a medication like Fluticasone/Salmeterol, which requires consistent use for optimal benefit in managing respiratory conditions.\n*   **Mental Health:** Intimate partner abuse is frequently associated with mental health issues like depression, anxiety, and PTSD. These conditions can further complicate medication adherence and overall health management.\n*   **Safety of Medication Storage:** There is a risk the abuser may withhold or tamper with the medication.\n\n**General Risks Associated with Fluticasone/Salmeterol (Advair)**\n\n*   **Cardiovascular Events:** Salmeterol, a component of Advair, is a long-acting beta-agonist (LABA). LABAs have been associated with an increased risk of asthma-related death in some studies, although this risk is debated. Patients with existing cardiovascular conditions should be monitored closely.\n*   **Immunosuppression:** Fluticasone, an inhaled corticosteroid, can cause local immunosuppression in the mouth and throat, leading to an increased risk of oral candidiasis (thrush). Patients should rinse their mouth with water after each use of the inhaler to minimize this risk.\n*   **Pneumonia:** Inhaled corticosteroids may increase the risk of pneumonia, especially in patients with COPD.\n*   **Adrenal Suppression:** While less likely with inhaled corticosteroids than with oral steroids, long-term use can potentially lead to adrenal suppression.\n*   **Bone Density Loss:** Long-term use of inhaled corticosteroids can contribute to bone density loss.\n\n**Important Considerations:**\n\n*   **Social Support:** The patient reports social isolation and limited social contact. Connecting the patient with resources and support services for survivors of intimate partner violence is crucial.\n*   **Mental Health Screening:** Given the history of abuse, regular mental health screening is important.\n\n**Recommendations:**\n\n*   **Assess Medication Adherence:** Inquire about any difficulties the patient may be experiencing in taking their medication as prescribed.\n*   **Counseling and Support:** Provide information about resources for victims of intimate partner violence, including local shelters, support groups, and legal aid.\n*   **Monitor for Side Effects:** Regularly assess the patient for any adverse effects of Fluticasone/Salmeterol, such as oral candidiasis or signs of respiratory infection.\n*   **Mental Health Support:** Offer mental health support and monitor for signs of depression, anxiety, or PTSD.\n*   **Safe Medication Storage:** Discuss safe medication storage practices, considering the patient's living situation.\n*   **Fall Risk:** Review medications and other fall risk factors for the patient.\n\n**Disclaimer:** This information is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 30,
        "patient_id": "b734c85d-0a1e-4d03-8b89-c19d2a6a1157",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Diastolic Blood Pressure: 80.0 progress for a patient with Social isolation (finding)? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 molfunc_protein 5515.",
        "llm_answer": "I am unable to answer your question. The provided knowledge graph does not contain information about the relationship between diastolic blood pressure, social isolation, and their progression. The provided facts relate to disease-protein and molfunc-protein associations which are not relevant to your question.\n",
        "rag_answer": "This query cannot be answered using the available information. The patient's chloride level is within normal range (98-106 mmol/L). Furthermore, the knowledge graph does not contain any information about how chloride levels might progress in patients with prediabetes.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 31,
        "patient_id": "e8503522-82ff-67a2-4dad-29281d6318de",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Full-time employment (finding) taking lisinopril 10 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph provided, here are some risks that should be considered for a patient with Full-time employment (finding) taking lisinopril 10 MG Oral Tablet:\n\n*   **5044:** Please provide further information on what this code refers to.\n*   **1200_1134_15512_5080_100078:** Please provide further information on what this code refers to.\n*   **992:** Please provide further information on what this code refers to.\n\n",
        "rag_answer": "I cannot answer the question about how the symptom Body Weight: 83.2 might progress for a patient with Chronic sinusitis (disorder) based on the provided information. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not contain information about the typical progression of body weight in patients with chronic sinusitis.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 32,
        "patient_id": "323a0bc9-41a7-bd5c-c431-eab5dca111f5",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom In the past year  have you been afraid of your partner or ex-partner?: No progress for a patient with Received higher education (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The patient reports \"No\" to being afraid of their partner or ex-partner in the past year. The fact that they have received higher education does not directly influence this symptom.",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains information about drug interactions and contraindications for a drug with ID DB01556, but it does not provide specific risks associated with \"Not in labor force (finding)\" or Acetaminophen 325 MG Oral Tablet.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 33,
        "patient_id": "6c590adb-27ed-cd72-963c-dd6ef39be384",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Housing unsatisfactory (finding) taking Acetaminophen 300 MG / Hydrocodone Bitartrate 5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some risks to consider for a patient with Housing unsatisfactory (finding) taking Acetaminophen 300 MG / Hydrocodone Bitartrate 5 MG Oral Tablet, based on contraindications:\n\n*   **DB01556 contraindication 5044**: This suggests a general contraindication, and further clarification would be needed to understand the specific risk.\n*   **DB01556 contraindication 1200\\_1134\\_15512\\_5080\\_100078**: This appears to be a specific code or identifier referencing a particular contraindication. Further details are needed to understand the nature of this risk.\n*   **DB01556 contraindication 992**: This suggests a specific contraindication, and further clarification would be needed to understand the specific risk.\n\nIt's important to consult the full prescribing information for Acetaminophen/Hydrocodone and to discuss the patient's specific circumstances with a healthcare professional to determine the relevance and severity of these potential contraindications. Additionally, \"Housing unsatisfactory (finding)\" may contribute to stress and could impact medication adherence or overall health management.",
        "rag_answer": "Ibuprofen (DB01556) has several contraindications that should be considered. The provided knowledge graph lists the following: 5044, 1200_1134_15512_5080_100078, and 992. Unfortunately, without more information about what these codes represent, I cannot provide specific details on the risks associated with these contraindications. You should consult with a healthcare professional or pharmacist for a comprehensive review of the risks of taking ibuprofen, especially considering the patient's acute bronchitis and other conditions.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 34,
        "patient_id": "1e7cdf67-1787-d1f1-5dbf-ee25aea4b493",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Pulmonary emphysema (disorder) taking Acetaminophen 325 MG Oral Tablet?",
        "llm_answer": "I am unable to answer this question. Acetaminophen 325 MG Oral Tablet does not carry specific risks for patients with Pulmonary emphysema (disorder).\n",
        "rag_answer": "Here are some risks to consider for a patient with chronic sinusitis taking Naproxen Sodium:\n\n*   **Gastrointestinal Issues:** Naproxen, like other NSAIDs, can increase the risk of stomach ulcers, bleeding, and perforation. The risk is higher in older adults and those with a history of ulcers or GI bleeding.\n*   **Cardiovascular Risks:** NSAIDs can increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. This risk may increase with the duration of use. Patients with pre-existing cardiovascular disease may be at greater risk.\n*   **Kidney Problems:** Long-term use of NSAIDs can lead to kidney damage, including acute kidney injury and chronic kidney disease.\n*   **Increased Blood Pressure:** Naproxen can lead to new onset or worsening of pre-existing hypertension.\n*   **Allergic Reactions:** Although less common, Naproxen can cause allergic reactions, including skin rash, hives, and anaphylaxis.\n*   **Interactions with Other Medications:** Naproxen can interact with other medications, such as blood thinners (e.g., warfarin), aspirin, and certain antidepressants.\n*   **Exacerbation of Sinusitis:** In rare cases, NSAIDs can exacerbate respiratory conditions, including sinusitis.\n*   **Fluid Retention and Edema:** NSAIDs can cause fluid retention, which may be a concern for individuals with certain medical conditions.\n*   **Age:** The risk of adverse events from NSAIDs, including Naproxen, increases with age.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 35,
        "patient_id": "d846a69a-fa5a-7d43-c0c5-c4c1ef578f54",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Creatinine: 1.2 progress for a patient with Part-time employment (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided information does not have any facts about how Creatinine: 1.2 might progress for a patient with Part-time employment (finding) or how it relates to DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain any information about how part-time employment might affect hematocrit levels. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 36,
        "patient_id": "5f26a8b2-4d58-59ef-c264-8d189ed7a933",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Are you Hispanic or Latino?: No progress for a patient with Not in labor force (finding)?",
        "llm_answer": "The symptom \"Are you Hispanic or Latino?: No\" is not directly related to the finding \"Not in labor force.\" Being Hispanic or Latino is an ethnicity, while \"Not in labor force\" describes an employment status. There is no direct clinical relationship between these two factors in terms of disease progression or lack of progress.\n",
        "rag_answer": "The symptom \"Which race(s) are you?: White\" is not a symptom that can progress. It is a demographic characteristic indicating the patient's race as White. First-degree burns primarily affect the outer layer of skin (epidermis). The typical progression of a first-degree burn involves:\n\n1.  **Initial appearance:** Redness, mild pain, and dry skin.\n2.  **Healing:** The burn usually heals within a week without scarring. The skin may peel as part of the healing process.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 37,
        "patient_id": "d8e88617-b8f0-d89f-b4f0-abdde20c59db",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Fall risk level [Morse Fall Scale]: High Risk (MFS Score 50+) progress for a patient with Acute bronchitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot provide a definitive prediction on how the symptom \"Fall risk level: High Risk\" might progress specifically due to acute bronchitis. Here's why:\n\n*   **Acute Bronchitis is Typically Self-Limiting:** Acute bronchitis is usually a temporary inflammation of the airways. While it can cause coughing and fatigue, it doesn't directly cause a *chronic* increase in fall risk.\n\n*   **Fall Risk is Multifactorial:** A high fall risk score is complex. It's influenced by many things, including:\n    *   Underlying medical conditions (like Alzheimer's in this patient's case)\n    *   Medications (some medications can cause dizziness or drowsiness)\n    *   Age-related changes in balance and strength\n    *   Environmental hazards\n    *   Acute illnesses *could* transiently worsen fall risk due to weakness, dizziness, or confusion, but bronchitis itself isn't usually a primary driver.\n\n*   **Limited Information:** I don't have enough information to determine *how* the bronchitis might impact the fall risk. For example, if the bronchitis causes severe coughing fits, that *could* lead to instability and a fall. Or, if the patient is prescribed sedating cough medicine, that *could* also increase fall risk temporarily.\n\n**In summary:** Acute bronchitis *could* temporarily worsen the existing high fall risk, but it's unlikely to be the primary cause of a sustained increase. The progression of the fall risk will depend more on managing the underlying conditions (like Alzheimer's), medication side effects, and addressing any new factors that arise due to the bronchitis (like fatigue or specific medications used to treat it).\n",
        "rag_answer": "Based on the provided information, I can offer some potential risks to consider for a patient with stress taking Galantamine:\n\n*   **Contraindications:** The knowledge graph indicates several contraindications for Galantamine (DB01556), represented by numerical codes. Unfortunately, without knowing what these codes (5044, 1200_1134_15512_5080_100078, 992, etc.) represent, I cannot provide specific details about these contraindications. You would need to consult a medical professional or a database that deciphers these codes to understand the exact nature of these risks.\n*   **Drug-Drug Interactions:** The knowledge graph lists numerous potential drug-drug interactions between Galantamine (DB01556) and other drugs (DB00328, DB00461, etc.). Again, without knowing the names of the drugs represented by these codes, I cannot determine if the patient is taking any of these medications. You would need to check the patient's medication list against a drug interaction database to identify any potential interactions.\n\n**Additional Considerations Based on Patient Profile:**\n\n*   **Stress:** While not a direct contraindication, the patient's stress levels should be monitored.\n*   **Other Conditions and Medications:** A comprehensive review of all the patient's conditions and medications is crucial to identify any potential risks or interactions associated with Galantamine.\n\n**Disclaimer:** I am an AI assistant and cannot provide medical advice. This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 38,
        "patient_id": "2fc1d429-375b-22be-1a5f-f07fa3eaba62",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What language are you most comfortable speaking?: English progress for a patient with Hypertension? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "The patient's preferred language (English) is unlikely to directly *progress* or change due to hypertension. Hypertension primarily affects the cardiovascular system. The provided facts about DB01556 (which seems to be a drug identifier, though without context, its specific relevance is unclear) and its contraindications (5044, 1200_1134_15512_5080_100078, and 5009) don't relate to language or communication abilities.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph describes drug interactions and contraindications for a drug identified as DB01556. To provide risks specific to amLODIPine for a patient with a history of drug overdose, I would need information about amLODIPine interactions and contraindications.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 39,
        "patient_id": "8702b04b-d1f1-fb3f-7787-dd74b3ddd8c3",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Calcium: 9.4 progress for a patient with Social isolation (finding)? Based on the knowledge graph which includes facts such as: 4878 disease_protein 5010; 4878 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 molfunc_protein 5515.",
        "llm_answer": "I cannot predict how Calcium: 9.4 might progress in a patient with Social isolation (finding) based on the provided knowledge graph. The knowledge graph focuses on disease-protein relationships and molecular functions of proteins, and does not contain any information about the progression of calcium levels in relation to social isolation.\n",
        "rag_answer": "I'm sorry, but the provided knowledge graph does not contain information about the risks associated with \"Received higher education (finding)\" or \"Vitamin B 12 5 MG/ML Injectable Solution\". Therefore, I cannot answer your question.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 40,
        "patient_id": "8dc2f066-f116-0180-277f-d4670b7caa6d",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Familial Alzheimer's disease of early onset (disorder) taking Galantamine 4 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 1541 drug_effect DB01024; 1541 drug_effect DB01165; 1541 drug_effect DB01137.",
        "llm_answer": "I am unable to provide medical advice. Please consult with a medical professional.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about the risks of Memantine hydrochloride 2 MG/ML Oral Solution (DB00959). The knowledge graph only contains information about contraindications of Memantine (DB00959).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 41,
        "patient_id": "1f3ccd29-4283-4d48-eec4-0b501cb2abfd",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Part-time employment (finding) taking NDA020503 200 ACTUAT Albuterol 0.09 MG/ACTUAT Metered Dose Inhaler? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I am unable to answer the question, as I don't have enough information to generate a response.",
        "rag_answer": "Based on the provided information, here are some risks to consider for a patient with limited social contact taking Acetaminophen/oxyCODONE:\n\n*   **Drug Interactions:** Acetaminophen/oxyCODONE has drug-drug interactions with DB00396.\n*   **Contraindications:** Acetaminophen/oxyCODONE is contraindicated with 5015 and 6920.\n*   **Exposure to Disease:** D008628, D002104 and D003634 are exposure to disease with 6920 and 5015.\n*   **Disease association:** 43 and 1621 disease are associated with 956 and 5384 proteins.\n\nIt's important to note that this information is based solely on the provided data. A comprehensive risk assessment should involve a thorough review of the patient's medical history, a physical examination, and potentially further investigation.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 42,
        "patient_id": "71d3115d-9b63-349a-c539-8e46f54d0397",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Served in armed forces (finding) taking 1 ML DOCEtaxel 20 MG/ML Injection? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, here are some risks to consider for a patient with a history of serving in the armed forces taking Docetaxel:\n\n*   **5044**: This code may refer to a specific contraindication or risk associated with Docetaxel. Further clarification is needed to understand the exact nature of this risk.\n*   **1200_1134_15512_5080_100078**: This string of codes likely represents a combination of contraindications or risks. Further details are needed to decipher the specific meanings of these codes and their relevance to the patient.\n*   **992**: This code might indicate another specific contraindication or risk factor. More information is required to determine the exact nature of this risk.\n\nAdditionally, it's important to consider these general risks associated with Docetaxel:\n\n*   **Contraindications**: Docetaxel has several contraindications that should be carefully evaluated before administration.\n*   **Specific Contraindications**: The codes provided (5044, 1200_1134_15512_5080_100078, and 992) likely point to specific contraindications that need to be investigated further to ensure patient safety.\n\n**Next Steps:**\n\nTo provide a more comprehensive assessment, it is essential to consult the detailed prescribing information for Docetaxel and investigate the specific meanings of the codes provided in the knowledge graph. This will help identify any potential risks or contraindications that are particularly relevant to a patient with a history of serving in the armed forces.",
        "rag_answer": "I cannot answer the question about the risks of taking Simvastatin 20 MG Oral Tablet, since the knowledge graph only contains information about drug interactions and contraindications for a drug with ID DB01556, but not about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 43,
        "patient_id": "d5fcf85c-fbb4-e758-7018-58d168b39a82",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Body Weight: 97.3 progress for a patient with First degree burn?",
        "llm_answer": "A first-degree burn typically only involves the outer layer of skin (epidermis) and is characterized by redness, pain, and mild swelling. It doesn't usually cause significant fluid loss or metabolic changes that would directly lead to a drastic change in body weight like 97.3.\n\nHowever, several indirect factors could influence body weight in a patient with a first-degree burn:\n\n*   **Fluid Retention:** While first-degree burns don't usually cause massive fluid shifts, localized inflammation can lead to some fluid retention in the affected area. This might cause a very minor, temporary increase in weight, but it wouldn't be substantial.\n*   **Decreased Activity:** Pain or discomfort from the burn might lead to reduced physical activity, potentially affecting metabolism and contributing to weight changes over a longer period. However, this is more relevant for more severe burns.\n*   **Dietary Changes:** The patient might experience a temporary loss of appetite due to discomfort or stress, leading to decreased food intake and potential weight loss. Conversely, they might overeat due to emotional distress, leading to weight gain.\n*   **Underlying Conditions:** It's important to consider the patient's existing conditions (Body mass index 30+ - obesity (finding)) and medications. These could independently influence weight changes.\n\nGiven the typically mild nature of a first-degree burn, significant weight fluctuations are unlikely unless other factors are involved. If the patient experiences unexpected weight changes, further evaluation is warranted to rule out other underlying medical conditions or complications.\n",
        "rag_answer": "Based on the patient's profile and the medication piperacillin/tazobactam, here are the risks to consider:\n\n*   **Sepsis and ARDS:** The patient has diagnoses of sepsis and acute respiratory distress syndrome (ARDS). Antibiotics like piperacillin/tazobactam are often used to treat sepsis, but it's important to monitor for signs of worsening infection or complications related to ARDS.\n\n*   **Kidney Function:** Piperacillin/tazobactam can affect kidney function.\n\n*   **Allergic Reactions:** Allergic reactions are a risk with any antibiotic, including piperacillin/tazobactam.\n\n*   **Clostridioides difficile Infection:** Antibiotics can disrupt the normal gut flora, leading to *Clostridioides difficile* infection.\n\n*   **Drug Interactions:** Review the patient's other medications (acetaminophen, vancomycin, norepinephrine) for potential interactions with piperacillin/tazobactam.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 44,
        "patient_id": "1ded4f39-fa12-544b-0a17-1050427df77b",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Ketones [Mass/volume] in Urine by Test strip: 16.3 progress for a patient with Not in labor force (finding)? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I cannot answer this question. The provided context includes the patient's conditions, medications, symptoms, and lab results. While the patient's employment status (Not in labor force) is mentioned, there is no information about how this might relate to the progression of ketones in the urine. Additionally, the knowledge graph provided (pathway_protein relationships) is not relevant to the question about ketone progression.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about risks associated with taking PACLitaxel 100 MG Injection while having Hypertriglyceridemia (disorder).\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 45,
        "patient_id": "49325aa6-5655-1d1f-5745-46902c91f3b9",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Severe anxiety (panic) (finding taking Simvastatin 20 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 disease_protein 5010.",
        "llm_answer": "Here are some risks to consider for a patient with severe anxiety (panic) taking Simvastatin:\n\n*   **Simvastatin and Anxiety:** While Simvastatin is primarily used to manage hyperlipidemia and reduce the risk of cardiovascular events, it's important to be aware of potential side effects and interactions that could exacerbate anxiety or panic symptoms.\n*   **Mental Health Side Effects:** Although less common, some statins have been associated with mental health side effects, including cognitive changes, depression, and anxiety. It's crucial to monitor the patient for any changes in mood or anxiety levels after starting Simvastatin.\n*   **Drug Interactions:** Simvastatin can interact with other medications, potentially increasing its side effects or reducing its effectiveness. The patient is taking multiple medications, so a thorough review of potential drug interactions is necessary.\n*   **Lifestyle Factors:** This patient has reports of violence in the environment, intimate partner abuse, and social isolation. These can significantly impact anxiety levels.\n*   **Comorbid Conditions:** The patient has multiple co-existing conditions (osteoarthritis, chronic low back pain, fibromyalgia) that can contribute to chronic pain and potentially exacerbate anxiety.\n\nGiven these considerations, it's essential to:\n\n*   **Monitor anxiety levels:** Regularly assess the patient's anxiety symptoms and overall mental well-being.\n*   **Educate the patient:** Inform the patient about the potential for mental health side effects from Simvastatin and encourage them to report any changes to their healthcare provider.\n*   **Consider alternative statins:** If Simvastatin appears to worsen anxiety symptoms, discuss with the prescribing physician whether an alternative statin with a lower risk of mental health side effects might be appropriate.\n*   **Address lifestyle factors:** Provide support and resources to address the patient's social isolation, exposure to violence, and intimate partner abuse, as these can significantly impact anxiety levels.\n*   **Pain Management:** Since chronic pain conditions can worsen anxiety, ensure their pain is well-managed.\n*   **Medication Review:** Given the number of medications the patient is on, it is important to ensure that there are no drug interactions that could be exacerbating anxiety.\n\n**Disclaimer:** This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.",
        "rag_answer": "Based on the provided information, I cannot determine how Urea Nitrogen levels specifically progress in Alzheimer's disease. The knowledge graph provides associations between a disease (represented by a number, possibly an identifier) and proteins. The patient's symptoms include a Urea Nitrogen level of 17.8. However, there's no direct link established between Alzheimer's and Urea Nitrogen levels or their progression in the provided data. More specific medical knowledge would be needed to answer this question accurately.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 46,
        "patient_id": "ac643af6-1a32-08ce-df40-1c31348bcb41",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Heart rate: 66.0 progress for a patient with Stress (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph does not contain information about the progression of heart rate in relation to stress. The information provided is related to contraindications of a drug (DB01556).\n",
        "rag_answer": "Based on the provided information:\n\n*   **Lisinopril (DB01556) Contraindications:** The knowledge graph lists several contraindications for Lisinopril (DB01556), represented by numerical codes. Without knowing what these codes signify, it's impossible to determine the specific risks.\n\nIt is important to consult with a healthcare professional or refer to comprehensive medical databases for detailed information on Lisinopril contraindications and potential risks associated with appendicitis.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 47,
        "patient_id": "f7019a56-1940-b131-f5e2-39439c16a942",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Refugee (person) taking Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "Based on the information provided, here are some considerations regarding a patient who is a refugee taking Amoxicillin/Clavulanate:\n\n*   **Contraindication:** Based on the knowledge graph, DB00304 (Amoxicillin/Clavulanate) has a contraindication with 5347.\n\n**Additional Considerations for Refugees:**\n\n*   **Adverse Effects:** Amoxicillin/Clavulanate is an antibiotic. Common side effects can include gastrointestinal issues such as nausea, vomiting, and diarrhea. Allergic reactions are also possible, ranging from mild rash to severe anaphylaxis.\n*   **Compliance:** Assess potential barriers to medication adherence.\n*   **Drug Interactions:** Always consider potential drug interactions, especially if the patient is taking other medications.\n*   **Renal Function:** The patient's creatinine levels have ranged from 2.5-3.4 which is elevated. The glomerular filtration rate is also low indicating decreased renal function. Amoxicillin/Clavulanate dosage may need adjustment in patients with impaired kidney function.\n*   **Hepatic Function:** This patient has multiple instances of elevated liver function which may need to be addressed prior to starting Amoxicillin/Clavulanate.\n*   **Pregnancy History:** This patient has a history of miscarriage and tubal pregnancy which may require special attention and monitoring while on Amoxicillin/Clavulanate.\n*   **Social Factors:** As the patient is a refugee and reports violence in the environment, and has limited social contact, it is important to make sure that Amoxicillin/Clavulanate is available to them and is taken safely.\n*   **Medication Access:** Consider the patient's access to pharmacies and ability to obtain refills.\n\n**Disclaimer:** This information does not constitute medical advice and is for informational purposes only. Always consult with a qualified healthcare professional for diagnosis and treatment.",
        "rag_answer": "Based on the provided information:\n\n*   **Albuterol (NDA020503)**: From the knowledge graph, DB00153 represents Albuterol.\n*   **Stress (finding)**: Stress is associated with the code 5347.\n\nThe knowledge graph states \"DB00153 contraindication 21187\\_11237\\_11470\" and \"DB00153 contraindication 1336\". However, there is no direct link found in the knowledge graph indicating a contraindication between Albuterol (DB00153) and Stress (5347). Therefore, the risks related to Stress and Albuterol cannot be determined.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 48,
        "patient_id": "322ab10f-3c76-7f32-7581-d96e262518c2",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Normal pregnancy taking Acetaminophen 325 MG Oral Tablet?",
        "llm_answer": "Risks to consider for a patient with a normal pregnancy taking Acetaminophen 325 MG Oral Tablet:\n\nAcetaminophen is generally considered safe during pregnancy when taken as directed for short-term pain relief or fever. However, like all medications, it's important to be aware of potential risks and use it judiciously. Here are some considerations:\n\n*   **Dosage and Duration:** It's crucial to adhere to the recommended dosage and duration of use. Avoid exceeding the recommended dose or taking it for prolonged periods without consulting a healthcare provider.\n*   **Potential Association with Developmental Outcomes:** Some studies have suggested a possible association between long-term acetaminophen use during pregnancy and certain developmental outcomes in children, such as an increased risk of attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). However, these associations are not definitive, and more research is needed to establish a causal relationship.\n*   **Liver Health:** Acetaminophen is metabolized by the liver, and excessive doses can potentially lead to liver damage. While rare at recommended doses, pregnant women with pre-existing liver conditions should exercise caution and consult their healthcare provider before using acetaminophen.\n*   **Kidney Health:** High doses of acetaminophen, especially when combined with other medications, may affect kidney function. If there are concerns, you should reach out to your healthcare provider.\n*   **Allergic Reactions:** Although uncommon, allergic reactions to acetaminophen can occur. Pregnant women should be aware of the signs and symptoms of an allergic reaction, such as rash, itching, swelling, or difficulty breathing, and seek immediate medical attention if they experience any of these symptoms.\n*   **Interaction with Other Medications:** Acetaminophen can potentially interact with certain medications, such as blood thinners (e.g., warfarin). It's important to inform the healthcare provider about all medications being taken to avoid potential drug interactions.\n*   **Underlying Medical Conditions:** Pregnant women with certain underlying medical conditions, such as liver disease, kidney disease, or bleeding disorders, should consult their healthcare provider before using acetaminophen to ensure it is safe and appropriate for their individual circumstances.\n*   **Risk of Overdose:** Acetaminophen is found in many over-the-counter medications, such as cough and cold remedies. Pregnant women should be careful not to exceed the maximum daily dose of acetaminophen by inadvertently taking multiple medications containing the drug.\n\n**Disclaimer:** This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.",
        "rag_answer": "I am unable to answer this question. The provided information does not contain any risks associated with Received certificate of high school equivalency (finding) taking Acetaminophen 325 MG Oral Tablet.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 0,
        "patient_id": "7562e458-cfcd-2ab3-f1f7-41665db2af63",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Not in labor force (finding) taking Jolivette 28 Day Pack? Based on the knowledge graph which includes facts such as: 12532 phenotype_protein 6335.",
        "llm_answer": "I am unable to answer this question. My pre-trained data does not contain any information about risks associated with \"Not in labor force (finding)\" and \"Jolivette 28 Day Pack\".\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains facts about the relationship between phenotypes and proteins, and does not contain information about the risks associated with taking Naproxen sodium 220 MG Oral Tablet for Acute viral pharyngitis.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 1,
        "patient_id": "4cc043f9-1872-e18b-d387-2eb492f075a7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Tobacco smoking status NHIS: Never smoker progress for a patient with Only received primary school education (finding)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "This patient's \"Tobacco smoking status NHIS: Never smoker\" is unlikely to change directly due to their \"Only received primary school education (finding).\" Educational attainment is a social determinant of health and can indirectly influence health behaviors, including smoking. People with lower educational attainment may have less access to information about the health risks of smoking, or they may be more likely to live in environments where smoking is more common. However, since the patient is currently a never-smoker, the lack of higher education itself won't cause them to start smoking. Other factors like peer influence, stress, or targeted marketing by tobacco companies could potentially lead to them starting to smoke in the future, but this is speculative.\n",
        "rag_answer": "I cannot determine how the symptom 'Body Weight: 69.2' might progress specifically for a patient with 'Misuses drugs (finding)' based on the provided knowledge graph. The knowledge graph focuses on protein and disease relationships, drug contraindications, and cellular components, but it does not contain information about how drug misuse directly impacts body weight.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 2,
        "patient_id": "94cecba2-18b0-72a1-334d-427ecbf4fdff",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Has a criminal record (finding) taking Loratadine 10 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph and the patient's condition of having a criminal record, there don't appear to be direct contraindications between having a criminal record and taking Loratadine. The provided contraindications (5044, 1200_1134_15512_5080_100078, and 992) do not relate to having a criminal record. Therefore, the patient can proceed with taking Loratadine, but should still follow their doctor's advice.\n",
        "rag_answer": "I cannot predict how the symptom \"Pain severity - 0-10 verbal numeric rating [Score] - Reported: 3.0\" might progress for this patient, nor can I use the provided knowledge graph to do so. The knowledge graph contains drug-related information (contraindications and drug-drug interactions for a drug with ID DB01556) and is not related to pain progression or the impact of education level on pain.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 3,
        "patient_id": "15e34bee-9f5e-e034-3e49-1406647f3b4d",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Limited social contact (finding) taking Alteplase 100 MG Injection? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "Here are the risks to consider for a patient with limited social contact taking Alteplase 100 MG Injection, based on the information available:\n\n*   **Contraindications of Alteplase:** The knowledge graph indicates contraindications related to '5044', '1200\\_1134\\_15512\\_5080\\_100078', and '5009'. To provide specific risks, I would need more details on what these codes represent. Please provide the definitions or descriptions of these codes to understand the exact nature of these contraindications.\n\nIt's important to note:\n\n*   **Alteplase is a high-risk medication.** It is typically used in emergency situations like stroke or cardiac arrest to break up blood clots.\n*   **Limited social contact,** while not a direct contraindication, can impact a patient's ability to understand and adhere to post-treatment instructions and follow-up care. It may also affect their ability to recognize and report any adverse effects they may experience after receiving Alteplase.\n\n**Recommendations:**\n\n1.  **Clarify Contraindications:** Please provide the definitions or descriptions for the codes '5044', '1200\\_1134\\_15512\\_5080\\_100078', and '5009' so I can give you specific risks associated with Alteplase.\n2.  **Assess Social Support:** Evaluate the patient's available social support network. Determine who can assist with monitoring, follow-up appointments, and medication management.\n3.  **Provide Clear Instructions:** Ensure the patient (and any available caregiver) receives clear, concise instructions on potential side effects, warning signs, and when to seek immediate medical attention. Use simple language and visual aids if necessary.\n4.  **Arrange Follow-Up:** Schedule frequent follow-up appointments to monitor the patient's progress and address any concerns promptly. Consider involving a social worker or case manager to help the patient access necessary resources and support services.\n5.  **Address Mental Health:** Given the patient's history of major depressive disorder, social isolation, and reports of violence in the environment, assess their current mental health status and provide appropriate referrals for counseling or psychiatric care.\n6.  **Medication Reconciliation:** Review all of the patient's medications to identify any potential drug interactions with Alteplase.\n7.  **Fall Risk:** The patient has a history of moderate to high fall risk. Take appropriate safety measures to prevent falls, such as providing assistive devices and modifying the home environment.\n\n**Disclaimer:** This information is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.\n",
        "rag_answer": "I am unable to answer this question. The patient's profile does include Alcoholism and Triglycerides level. However, I do not have the ability to predict how Triglycerides level might progress.\n",
        "base_correct": true,
        "rag_correct": false
    },
    {
        "question_id": 4,
        "patient_id": "d31efc1d-0594-002a-61f2-4eee3a4c8cec",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What is your current work situation?: Full-time work progress for a patient with Polyp of colon? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The provided information does not discuss the progression of \"What is your current work situation?: Full-time work\" in relation to a colon polyp. Additionally, the provided knowledge graph (DB01556 contraindications) is not relevant to the question.\n",
        "rag_answer": "I am sorry, I cannot answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556) and does not include information about the progression of Urea Nitrogen levels in relation to stress.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 5,
        "patient_id": "ed1f5200-78a5-de4b-0c49-bf64c98ecae8",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Transport problems (finding) taking Acetaminophen 325 MG Oral Tablet?",
        "llm_answer": "I am unable to answer this question. Acetaminophen 325 MG Oral Tablet is a common medication, and there are no contraindications listed based on the patient's conditions, medications, or symptoms. I am unable to provide a comprehensive list of risks. Please consult a medical professional for further evaluation.\n",
        "rag_answer": "I am unable to predict how the symptom \"What address do you live at?: 790 Hamill Promenade\" might progress, as it is not a symptom but rather an address. I can answer questions about symptoms related to Viral sinusitis (disorder), if you have any.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 6,
        "patient_id": "5c68d61d-ff44-a6f2-fabd-1cf309196a1d",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Pain severity - 0-10 verbal numeric rating [Score] - Reported: 0.0 progress for a patient with Streptococcal sore throat (disorder)? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph does not contain information about streptococcal sore throat or pain severity.\n",
        "rag_answer": "I cannot predict how the symptom \"Chloride: 102.0\" might progress specifically for a patient with stress based on the provided information. The knowledge graph includes facts about diseases, proteins, and biological processes, but it doesn't contain information about the direct relationship between stress and chloride levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 7,
        "patient_id": "6666bcfc-4f47-9993-ddfe-2691afdc4696",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom MCV [Entitic volume] by Automated count: 88.8 progress for a patient with Not in labor force (finding)?",
        "llm_answer": "The patient's MCV (Mean Corpuscular Volume) is 88.8. This value falls within the normal range (typically 80-100 fL). Therefore, I cannot predict how the MCV will progress based on the fact that the patient is \"Not in labor force (finding)\".\n",
        "rag_answer": "Here are some risks to consider for a patient with acute bacterial sinusitis taking Abuse-Deterrent 12 HR Oxycodone Hydrochloride 10 MG Extended Release Oral Tablet [Oxycontin]:\n\n*   **Respiratory Depression:** Oxycodone can cause significant respiratory depression, especially in individuals with pre-existing respiratory conditions like pulmonary emphysema. This risk is heightened when combined with other medications that depress the central nervous system.\n*   **Addiction and Abuse Potential:** Oxycodone is an opioid with a high potential for abuse and addiction. Patients with a history of substance abuse or those with risk factors such as \"Has a criminal record (finding)\" or \"Reports of violence in the environment (finding)\" may be at higher risk. The \"Abuse-Deterrent\" formulation aims to reduce this risk, but does not eliminate it.\n*   **Central Nervous System (CNS) Depression:** Oxycodone can cause drowsiness, dizziness, and impaired cognitive function. This can be exacerbated by other CNS depressants.\n*   **Gastrointestinal Effects:** Opioids like oxycodone can cause constipation, nausea, and vomiting.\n*   **Interactions:** Oxycodone can interact with other medications, potentially increasing the risk of side effects or reducing the effectiveness of either medication.\n*   **Risk of Overdose:** Overdose can occur, leading to respiratory depression, coma, and death.\n*   **Tolerance and Dependence:** With prolonged use, tolerance to oxycodone can develop, requiring higher doses to achieve the same level of pain relief. Physical dependence can also occur, leading to withdrawal symptoms if the medication is abruptly discontinued.\n*   **Withdrawal Symptoms:** Abrupt cessation of oxycodone can lead to withdrawal symptoms such as restlessness, muscle and bone pain, insomnia, diarrhea, vomiting, and goosebumps.\n*   **Intimate Partner Abuse:** Given the patient's history of being a victim of intimate partner abuse, it's important to consider whether the medication could be misused by an abuser or if access to the medication could create a dangerous situation.\n*   **Mental Health:** The patient also reports stress, which could potentially be worsened by opioid use due to its impact on mood and cognitive function.\n\nGiven the patient's history, a non-opioid pain reliever might be a better choice.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 8,
        "patient_id": "b8f0f7fa-c623-67e2-6434-d1ddb63de9df",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom MCV [Entitic volume] by Automated count: 86.3 progress for a patient with Limited social contact (finding)? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I am unable to answer your question. The provided information does not include details on how \"MCV [Entitic volume] by Automated count: 86.3\" might progress in a patient with limited social contact. Additionally, the provided knowledge graph does not give insights into this topic.",
        "rag_answer": "I cannot predict how Systolic Blood Pressure might progress in a patient with Myocardial Infarction based on the provided knowledge graph. The provided facts relate to protein pathways and drug interactions/contraindications of Nitroglycerin, which are not directly related to predicting the progression of systolic blood pressure in myocardial infarction.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 9,
        "patient_id": "6ad59647-a0db-2a01-dca6-087b48bfb805",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom What language are you most comfortable speaking?: Language other than English progress for a patient with Hyperlipidemia? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The patient's preferred language does not have a direct relationship with the progression of Hyperlipidemia.\n",
        "rag_answer": "Based on the provided information, I can offer some potential considerations:\n\n*   **Lisinopril Contraindications:** The knowledge graph indicates several contraindications for lisinopril (DB01556), represented by numerical codes. Without knowing what these codes stand for, it's difficult to provide specific details. Generally, contraindications are conditions or situations where a drug should not be used.\n\nIt's important to consult with the patient's oncologist and/or primary care physician for a comprehensive risk assessment. They can consider the patient's full medical history, current health status, and potential interactions with other medications or treatments.",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 10,
        "patient_id": "4d3204cc-fbbe-77ba-8a8c-ea49d0422d33",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Do you feel physically and emotionally safe where you currently live?: Yes progress for a patient with Housing unsatisfactory (finding)?",
        "llm_answer": "Given the patient's profile, particularly the \"Housing unsatisfactory (finding)\" and \"Victim of intimate partner abuse (finding),\" the symptom \"Do you feel physically and emotionally safe where you currently live?: Yes\" is concerning. While the patient currently reports feeling safe, the presence of unsatisfactory housing and a history of intimate partner abuse suggests potential instability and risk.\n\nHere's how the symptom might progress:\n\n*   **Initial Denial/Suppression:** The patient may initially report feeling safe as a coping mechanism or due to fear of repercussions from their abuser or landlord. They may minimize their concerns to avoid further conflict or maintain a sense of control.\n*   **Gradual Erosion of Safety:** As the unsatisfactory housing situation persists (e.g., due to safety concerns), or if the intimate partner abuse continues or escalates, the patient's sense of safety is likely to erode. They may start experiencing increased anxiety, hypervigilance, and fear.\n*   **Eventual Disclosure/Help-Seeking:** If the situation becomes unbearable or if the patient feels supported enough to disclose their true feelings, they may eventually admit that they do not feel safe. This could be triggered by a specific incident or a gradual buildup of stress.\n*   **Fluctuations in Perception:** Depending on the stability of their housing situation and the status of their relationship with their partner/ex-partner, their perception of safety may fluctuate. There may be periods of relative calm where they feel safer, followed by periods of increased fear and vulnerability.\n\nIt's important to note that the patient's report of feeling safe may not accurately reflect their true situation. It is crucial to:\n\n*   **Monitor the Patient Closely:** Regularly assess the patient's housing situation, relationship status, and overall well-being. Look for non-verbal cues (e.g., anxiety, fear) that may contradict their verbal report.\n*   **Provide a Safe and Supportive Environment:** Create a space where the patient feels comfortable disclosing their true feelings without fear of judgment or retaliation.\n*   **Offer Resources and Support:** Provide information about domestic violence shelters, housing assistance programs, and mental health services.\n*   **Respect Patient Autonomy:** While it's important to express concern and offer help, respect the patient's right to make their own decisions. Avoid pressuring them to take action they are not ready for.",
        "rag_answer": "The patient's total cholesterol is 192.3 mg/dL. The progression of this symptom in a patient with limited social contact is difficult to predict with certainty, as it depends on various factors, including diet, exercise, genetics, and other underlying health conditions. However, limited social contact can contribute to poorer health outcomes in several ways. It may be associated with unhealthy lifestyle choices, such as poor diet and lack of exercise, which can negatively impact cholesterol levels. Social isolation can also lead to increased stress and depression, which may also affect cholesterol levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 11,
        "patient_id": "233e8b42-45d4-726a-65c9-2490d752beda",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Full-time employment (finding) taking Hydrochlorothiazide 25 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The following risks should be considered for a patient with full-time employment taking Hydrochlorothiazide:\n*   **Electrolyte Imbalance:** Hydrochlorothiazide can cause imbalances in electrolytes such as potassium, sodium, and magnesium.\n*   **Increased Risk of Gout:** Hydrochlorothiazide can increase uric acid levels, potentially leading to gout.\n*   **Other Contraindications:** Review the full prescribing information for hydrochlorothiazide to identify all potential contraindications.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not provide information about the relationship between educational attainment and stress levels.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 12,
        "patient_id": "9e83f507-cebb-a7e5-5a9b-aea2d6d2c8f4",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Are you worried about losing your housing?: No progress for a patient with Atrial Fibrillation? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5098; DB00304 contraindication 11057; DB00304 contraindication 20671.",
        "llm_answer": "The patient's statement \"Are you worried about losing your housing?: No\" doesn't directly relate to Atrial Fibrillation or the contraindications of DB00304 (Alteplase), which are:\n\n*   **5098:** This ID doesn't provide enough information without additional context.\n*   **11057:** This ID doesn't provide enough information without additional context.\n*   **20671:** This ID doesn't provide enough information without additional context.\n\nHowever, housing stability is a social determinant of health. While not directly impacting the *symptoms* of Atrial Fibrillation, housing insecurity could indirectly affect the patient's ability to manage their condition. For example, it could impact their ability to:\n\n*   Attend appointments for monitoring and treatment.\n*   Afford medications.\n*   Maintain a stable lifestyle that supports heart health (e.g., diet, stress management).\n\nSince the patient is not worried about losing their housing, this particular social determinant is not a current concern in their Atrial Fibrillation management.\n",
        "rag_answer": "Some risks to consider for a patient taking Verapamil Hydrochloride 40 MG (DB00304) include contraindications related to the conditions 5098, 11057, and 20671. Please consult with a healthcare professional for a complete list of risks and contraindications.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 13,
        "patient_id": "3a39b848-0e35-b237-2813-dc81be049590",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute viral pharyngitis (disorder) taking Naproxen sodium 220 MG Oral Tablet?",
        "llm_answer": "Potential risks to consider for a patient with acute viral pharyngitis taking naproxen sodium include:\n\n*   **Gastrointestinal Issues:** Naproxen, an NSAID, can cause stomach upset, ulcers, and bleeding.\n*   **Cardiovascular Risks:** NSAIDs may increase the risk of heart attack or stroke, especially with long-term use or in patients with existing heart conditions.\n*   **Kidney Problems:** Naproxen can affect kidney function, especially in those with pre-existing kidney disease or dehydration.\n*   **Increased Bleeding Risk:** Naproxen can interfere with blood clotting and increase the risk of bleeding, particularly if the patient is taking other medications that affect clotting.\n*   **Allergic Reactions:** Although less common, allergic reactions to naproxen are possible.\n*   **Drug Interactions:** Naproxen can interact with other medications, so it's important to review all medications the patient is taking.\n*   **Fall Risk:** Considering the patient's history of high fall risk, NSAIDs may increase this risk further.\n*   **Exacerbation of high blood pressure:** Naproxen can lead to increased blood pressure.\n*   **Edema:** Naproxen may cause fluid retention.\n*   **Hepatic effects:** Elevated liver enzymes and liver damage are possible.\n\nGiven the patient's history, including prior fracture and social determinants of health, these risks should be carefully considered when prescribing naproxen. It is also important to note that since the patient has Acute viral pharyngitis, Naproxen will treat the pain, but not the underlying viral infection.",
        "rag_answer": "I am unable to predict how the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 might progress for a patient with Received certificate of high school equivalency (finding).",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 14,
        "patient_id": "753bd740-7680-1035-0692-edaf6d545dbe",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Victim of intimate partner abuse (finding) taking Captopril 25 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB00304 contraindication 5010; DB00304 contraindication 5068; DB00304 contraindication 6652_3678_1090_3672_3673_3676_3677_3679_6803.",
        "llm_answer": "Based on the provided information, here are some risks to consider for a patient who is a victim of intimate partner abuse and taking Captopril:\n\n*   **Contraindications:** The knowledge graph indicates several contraindications for Captopril (DB00304), referenced by codes 5010, 5068, and a complex code (6652\\_3678\\_1090\\_3672\\_3673\\_3676\\_3677\\_3679\\_6803). Without knowing what these codes specifically refer to, it's impossible to elaborate on those specific risks. Further clarification is needed from the medical knowledge graph.\n\n**General Considerations Regarding Intimate Partner Abuse and Medical Treatment:**\n\nWhile not directly related to Captopril's pharmacological action, it's crucial to remember the following:\n\n*   **Safety:** The patient's safety is paramount. Assess if taking medication at home is safe, given the abuse. Consider discreet ways to store or administer medication if necessary.\n*   **Mental Health:** Intimate partner abuse significantly impacts mental health. This patient presents with a PHQ-9 score of 21, which suggests severe depression. Victim of intimate partner abuse (finding) and Stress (finding) are also listed.\n*   **Adherence:** Stress and potential control by the abuser can affect adherence to the medication regimen.\n*   **Social Support:** The patient reports experiencing social isolation and has housing worries. Limited social contact may impact their ability to seek help or manage their health.\n*   **Further Evaluation of risk of suicide and/or harm to others.** Given the constellation of depression and intimate partner violence and other social determinants of health concerns, it is important to assess the patient for risk of suicide or homicide.\n\n**It is important to consult the medical knowledge graph for definitions of the contraindication codes. Additionally, a comprehensive approach to the patient's care is needed, considering both their physical and social/emotional well-being.**\n",
        "rag_answer": "I am unable to answer this question. The provided medical knowledge does not contain information about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": false
    },
    {
        "question_id": 15,
        "patient_id": "541118ce-e381-8922-83b7-3547e3f30076",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Body Mass Index: 24.4 progress for a patient with Social isolation (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The patient's Body Mass Index (BMI) of 24.4 falls within the healthy weight range (18.5-24.9). Social isolation can sometimes lead to changes in eating habits and physical activity levels. For some, it might lead to decreased appetite and weight loss due to depression or lack of motivation to cook and eat. In other cases, it can contribute to increased food intake and decreased physical activity, potentially leading to weight gain and a higher BMI. Since I don't have information on how their social isolation specifically affects their lifestyle, I can't predict whether their BMI will increase, decrease, or stay the same.\n",
        "rag_answer": "Lisinopril (DB01556) is contraindicated (contraindication) in pregnancy (5044, 1200_1134_15512_5080_100078, 992). Therefore, Lisinopril should not be used during normal pregnancy.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 16,
        "patient_id": "90e6fe32-d67b-96cc-bbd6-94aa94d0b20c",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Pain severity - 0-10 verbal numeric rating [Score] - Reported: 1.0 progress for a patient with Acute viral pharyngitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question with the information I have. The provided information does not include the typical progression of the symptom \"Pain severity - 0-10 verbal numeric rating [Score] - Reported: 1.0\" for a patient with Acute viral pharyngitis (disorder). Also, the knowledge graph is not about acute viral pharyngitis (disorder), so I cannot use it to answer the question.\n",
        "rag_answer": "Based on the provided information, the knowledge graph indicates that amLODIPine (DB01556) has several contraindications (5044, 1200_1134_15512_5080_100078, 992, etc.) and drug-drug interactions. However, none of the listed contraindications specifically mention social isolation. It's crucial to consult a comprehensive medical reference or a healthcare professional to determine the specific risks associated with amLODIPine in patients with social isolation. Social isolation itself might influence medication adherence or the patient's ability to recognize and report adverse effects, which should be considered.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 17,
        "patient_id": "5f5de9db-8676-bafc-06d3-cc24416c72b4",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Hypertension taking Acetaminophen 325 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the information available, here are some risks to consider for a patient with hypertension taking Acetaminophen 325 MG Oral Tablet:\n\n*   **Hypertension:** Acetaminophen might have an interaction with hypertension.\n*   **Cardiovascular Issues:** Acetaminophen is contraindicated in patients with certain cardiovascular conditions.\nIt's important to note that this information is not exhaustive, and other risks may exist. Always consult with a healthcare professional for personalized medical advice.",
        "rag_answer": "The symptom \"In the past year have you spent more than 2 nights in a row in a jail prison detention center or juvenile correctional facility?: No\" does not directly relate to the progress of Acute Bronchitis. It's a social history question that could be relevant to overall health and well-being but wouldn't typically be used to assess the progress of bronchitis treatment. The provided medical knowledge graph also does not contain information related to acute bronchitis or incarceration.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 18,
        "patient_id": "dc66d338-11bd-8ca6-d020-7b0bc2acf8a1",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Which race(s) are you?: White progress for a patient with Social isolation (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "The symptom \"Which race(s) are you?: White\" is a demographic characteristic and not a symptom that progresses or changes due to social isolation. Social isolation is more likely to affect mental and emotional well-being, potentially leading to symptoms like depression, anxiety, and decreased overall quality of life.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph includes information about drug interactions and contraindications for a drug with ID DB01556. To provide an answer, the drug ID for Acetaminophen 325 MG Oral Tablet is needed.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 19,
        "patient_id": "b9f5b378-f8cb-7c98-b8e9-0dee64335112",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Fetus with unknown complication taking Etonogestrel 68 MG Drug Implant? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "This patient has a fetus with unknown complication and is taking Etonogestrel. Here are some risks associated with Etonogestrel 68 MG Drug Implant (DB01556) that should be considered:\n\n*   **Contraindications:** The drug is contraindicated in certain situations (represented by codes 5044, 1200_1134_15512_5080_100078, and 992). I am unable to elaborate further without more information regarding what these codes represent.\n\nGiven the presence of a \"fetus with unknown complication,\" it is essential to consult the prescribing information and/or a physician about the suitability and potential risks of etonogestrel during pregnancy.",
        "rag_answer": "Based on the provided information:\n\n*   **Camila 28 Day Pack** contains norethindrone, which has DrugBank ID DB01556.\n*   The knowledge graph (PrimeKG) lists several contraindications for DB01556 (norethindrone), including \"5044\", \"1200\\_1134\\_15512\\_5080\\_100078\", and \"992\". However, the specific conditions these codes represent are not defined in the given context.\n\nGiven the patient's profile, the most relevant risk to consider is the **Tubal pregnancy**. Ectopic pregnancy is a contraindication for DB01556.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 20,
        "patient_id": "2e313061-dc85-c9a1-2442-d29aa9fc4798",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Overlapping malignant neoplasm of colon taking losartan potassium 50 MG Oral Tablet?",
        "llm_answer": "Here are some risks to consider for a patient with Overlapping malignant neoplasm of colon taking losartan potassium 50 MG Oral Tablet:\n\n*   **Losartan and Kidney Function:** Losartan can affect kidney function, and patients with existing kidney problems or those who are dehydrated may be at higher risk. Since the patient has a history of Chronic Congestive Heart Failure, kidney function could already be compromised, increasing the risk. Lab results show a range of Creatinine levels from 1.0 to 1.1, and Glomerular filtration rate ranging from 110.6 to 151.1, so monitoring is warranted.\n*   **Losartan and Electrolyte Imbalance:** Losartan can sometimes cause high potassium levels (hyperkalemia). This is more likely in patients with kidney problems, diabetes, or those taking other medications that can raise potassium. The patient's potassium levels range from 3.9 to 5.2.\n*   **Losartan and Hypotension:** Losartan can lower blood pressure, and in some cases, this can lead to dizziness or lightheadedness, especially when starting the medication. The patient has recordings of low systolic blood pressure.\n*   **Losartan and Anemia:** Losartan can potentially exacerbate anemia in some individuals. Patient has a history of anemia. Lab results show Hemoglobin levels ranging 11.6 to 17.3.\n\n**Overlapping Malignant Neoplasm of Colon:**\n*   **General Cancer Considerations**: The primary concern is the cancer itself. Treatment options (surgery, chemotherapy, radiation) will depend on the stage and location of the cancer.\n*   **Bleeding Risk**: Colon cancer, especially if it's advanced or ulcerated, can cause bleeding. This can lead to anemia or worsen existing anemia. Monitor hemoglobin levels. Patient has a history of anemia.\n*   **Surgical Risks**: If surgery is planned, standard surgical risks apply, including infection, bleeding, blood clots, and complications related to anesthesia.\n*   **Nutritional Issues**: Colon cancer can sometimes interfere with nutrient absorption, leading to weight loss or deficiencies. The patient's weight has been recorded between 91.4 and 97.7.\n*   **Bowel Obstruction**: Depending on the location and size of the tumor, there's a risk of bowel obstruction.\n\n*This information is not exhaustive and does not cover all possible risks or considerations. Always consult with a qualified healthcare professional for personalized medical advice and treatment.*",
        "rag_answer": "Here are some risks to consider for a patient with shock taking losartan potassium:\n\n*   **Hypotension:** Losartan can lower blood pressure. In a patient with shock, who may already have low blood pressure, losartan could exacerbate this, leading to further compromise of vital organ perfusion.\n*   **Hyperkalemia:** Losartan can increase potassium levels. Shock can sometimes be associated with kidney dysfunction, which can also lead to increased potassium. The combination can result in dangerous hyperkalemia.\n*   **Acute Kidney Injury:** Because losartan affects blood pressure and kidney function, it could worsen kidney injury in the setting of shock.\n*   **Drug Interactions:** Losartan can interact with other medications that might be used in the treatment of shock, potentially leading to unpredictable effects.\n\nIt is important to note that the decision to administer losartan to a patient in shock should be made carefully, considering the potential risks and benefits, and with close monitoring of the patient's blood pressure, kidney function, and potassium levels.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 21,
        "patient_id": "7423e440-7a9a-7bd7-63bd-9da82a500912",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom In the past year  have you been afraid of your partner or ex-partner?: Yes progress for a patient with Chronic sinusitis (disorder)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question. The provided knowledge graph is not helpful in determining how the symptom \"In the past year have you been afraid of your partner or ex-partner?: Yes\" might progress for a patient with chronic sinusitis. Chronic sinusitis is a respiratory condition, while fear of a partner is related to interpersonal relationships and safety. These two elements are not directly linked.\n",
        "rag_answer": "I am unable to answer the question. The patient's profile includes 'Received certificate of high school equivalency (finding)' which is not relevant in this context. The question is asking about risks associated with taking Naproxen, and there is no DrugBank ID that matches 'Naproxen sodium 220 MG Oral Tablet' in the knowledge graph.",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 22,
        "patient_id": "fc88755b-6767-bfb6-aa78-584a66b8a139",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute viral pharyngitis (disorder) taking Verapamil Hydrochloride 40 MG? Based on the knowledge graph which includes facts such as: 3784 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4635 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 disease_protein 5010.",
        "llm_answer": "Based on the available information, I cannot provide specific risks associated with taking Verapamil Hydrochloride 40 MG while having acute viral pharyngitis. To assess potential risks, it's crucial to consult with a healthcare professional who can evaluate the patient's complete medical history, current medications, and the specifics of their condition. They can then provide personalized advice and monitor for any potential drug interactions or adverse effects.\n",
        "rag_answer": "I can not answer this question. The provided knowledge graph does not contain information about risks associated with Digoxin or part-time employment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 23,
        "patient_id": "f20df06a-4d56-c80d-95c2-a548c65407f7",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Housing unsatisfactory (finding) taking Sertraline 100 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 10898 disease_protein 5649; 995 disease_protein 5090_13498_8414_10897_33312_10943_11552_14092_12054_11960_11280_11294_11295_11298_11307_11498_12879_13089_13506; 995 cellcomp_protein 5737.",
        "llm_answer": "I cannot answer the question because the provided knowledge graph does not contain information about the risks associated with \"Housing unsatisfactory (finding)\" and taking \"Sertraline 100 MG Oral Tablet\". The knowledge graph only contains information about disease-protein and cellcomp_protein relationships.\n",
        "rag_answer": "Based on the patient's profile, their pain severity has been reported at different times as 2.0, 3.0, 1.0 and 4.0. I am unable to predict the future progression of the symptom.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 24,
        "patient_id": "9908c417-0d2f-3873-face-1036e1de4ca0",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Not in labor force (finding) taking Naproxen sodium 220 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 1265.",
        "llm_answer": "I am unable to answer your question. The provided information does not contain any risks associated with patients \"Not in labor force (finding)\" taking \"Naproxen sodium 220 MG Oral Tablet\". Instead, the knowledge graph contains facts such as DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 1265.\n",
        "rag_answer": "I am sorry, I cannot answer this question. The provided information does not include details on how \"Risk activity involvement (finding)\" might affect the progression of the symptom \"DALY: 46.0\". The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), which is not directly relevant to the question about symptom progression in relation to risk activity involvement.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 25,
        "patient_id": "7d4b6d95-1852-4e50-06f6-3af6262505f6",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Heart rate: 75.0 progress for a patient with Not in labor force (finding)? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "I cannot determine how the symptom \"Heart rate: 75.0\" might progress for a patient with \"Not in labor force (finding)\" based on the provided information. The knowledge graph entries you included do not offer relevant insights into this specific relationship. To answer your question, I would need information that directly links a patient's employment status to their heart rate or cardiovascular health.\n",
        "rag_answer": "Based on the information provided, I cannot directly assess the risks of taking Acetaminophen for a second-degree burn. However, I can provide some general considerations:\n\n*   **Acetaminophen (Tylenol)**: This is a common pain reliever and fever reducer.\n*   **Second-degree burn**: This type of burn involves damage to the epidermis and part of the dermis. Pain management is often a key part of treatment.\n\n**Important Considerations:**\n\n*   **Liver Toxicity:** Acetaminophen can cause liver damage, especially at high doses or in individuals with pre-existing liver conditions.\n\n**Given the limitations of the provided information, it's essential to consult with a healthcare professional for personalized medical advice.** They can assess the patient's specific situation, including the severity of the burn, other medical conditions, and current medications, to determine the most appropriate and safe pain management strategy.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 26,
        "patient_id": "43a3e92e-50b8-1c12-6381-c4d240fe8fa7",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]: 1.0 progress for a patient with Miscarriage in first trimester? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am sorry, I cannot answer this question. The provided information does not contain details about the progression of Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]: 1.0 for a patient with Miscarriage in first trimester, nor does it explain how the given facts relate to the question.\n",
        "rag_answer": "I cannot answer this question. The provided knowledge graph contains drug interactions and contraindications for a specific drug (Meperidine Hydrochloride, DB01556). It does not contain any information about the progression of calcium levels in patients with limited social contact.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 27,
        "patient_id": "90fda2aa-a5e8-ad7c-f2f7-ecc2bb687514",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Diastolic Blood Pressure: 86.0 progress for a patient with Victim of intimate partner abuse (finding)?",
        "llm_answer": "Intimate partner violence (IPV) can significantly impact a person's health, including their blood pressure. In the context of IPV, diastolic blood pressure, like 86.0, could potentially progress in several ways:\n\n1.  **Elevated Diastolic Blood Pressure:** The stress and anxiety associated with IPV can lead to a sustained increase in blood pressure, including the diastolic reading. The chronic stress response can cause the body to release hormones like cortisol and adrenaline, which can elevate blood pressure over time.\n2.  **Fluctuations in Blood Pressure:** The patient might experience erratic blood pressure readings, with spikes during or immediately following abusive incidents, and potentially lower readings at other times. This variability can be due to the acute stress response and subsequent attempts by the body to return to a state of equilibrium.\n3.  **Masked Hypertension:** Some individuals might exhibit normal blood pressure readings in a clinical setting but have elevated blood pressure at home due to the stress and fear associated with IPV. This phenomenon, known as masked hypertension, can only be detected through ambulatory blood pressure monitoring.\n4.  **Increased Risk of Hypertension:** Over the long term, chronic stress from IPV can increase the risk of developing sustained hypertension (high blood pressure). Untreated hypertension can lead to serious health complications such as heart disease, stroke, and kidney problems.\n\nIt's important to note that the effects of IPV on blood pressure can vary depending on the individual, the severity and frequency of the abuse, and the person's coping mechanisms. Regular monitoring of blood pressure, along with appropriate support and interventions for IPV, are crucial in managing and mitigating these potential effects.\n",
        "rag_answer": "Here are some risks to consider for a patient with stress taking Ibuprofen:\n\n*   **Gastrointestinal Issues:** Ibuprofen can increase the risk of stomach ulcers, bleeding, and other gastrointestinal problems. Stress can also exacerbate these issues.\n*   **Cardiovascular Risks:** Ibuprofen, especially at high doses, may increase the risk of heart attack or stroke.\n*   **Kidney Problems:** Long-term use of ibuprofen can lead to kidney damage.\n*   **Drug Interactions:** Ibuprofen can interact with other medications, potentially increasing the risk of side effects.\n*   **Increased Stress Levels:** While ibuprofen can help manage pain and inflammation, it does not address the underlying cause of stress. Relying solely on medication may prevent the patient from seeking more effective stress management strategies.\n*   **Mental Health:** Stress can affect mental health, and some pain relievers can have mood-altering side effects or interact with medications used to treat mental health conditions.\n*   **Addiction:** Prolonged use of pain relievers can lead to dependence and addiction.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 28,
        "patient_id": "8ede6eac-1785-055f-411b-43a507a69f78",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Hematocrit [Volume Fraction] of Blood by Automated count: 49.6 progress for a patient with Coronary Heart Disease? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about how Hematocrit levels might progress in a patient with Coronary Heart Disease, nor does it offer any insights related to the provided facts.\n",
        "rag_answer": "I cannot directly answer how \"Fall risk level [Morse Fall Scale]: Low Risk (MFS Score 0 - 24)\" might progress specifically for a patient with \"Acute viral pharyngitis (disorder)\" as the provided knowledge graph does not contain information relating to fall risk or acute viral pharyngitis. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 29,
        "patient_id": "8d94532e-87ce-486d-adfc-bfa423b11dd2",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom QALY: 91.5 progress for a patient with Received higher education (finding)?",
        "llm_answer": "I am unable to determine how QALY: 91.5 might progress for a patient with Received higher education (finding) as I do not have sufficient information on QALY and its relationship to education.",
        "rag_answer": "Okay, based on the patient's profile and the medication they are taking, here's a breakdown of the risks to consider:\n\n**Risks Related to Intimate Partner Abuse and Medication**\n\n*   **Medication Adherence:** Intimate partner abuse can significantly impact a patient's ability to adhere to their medication regimen. Stress, fear, and control by the abuser can all interfere with taking medication as prescribed. This is especially concerning for a medication like Fluticasone/Salmeterol, which requires consistent use for optimal benefit in managing respiratory conditions.\n*   **Mental Health:** Intimate partner abuse is frequently associated with mental health issues like depression, anxiety, and PTSD. These conditions can further complicate medication adherence and overall health management.\n*   **Safety of Medication Storage:** There is a risk the abuser may withhold or tamper with the medication.\n\n**General Risks Associated with Fluticasone/Salmeterol (Advair)**\n\n*   **Cardiovascular Events:** Salmeterol, a component of Advair, is a long-acting beta-agonist (LABA). LABAs have been associated with an increased risk of asthma-related death in some studies, although this risk is debated. Patients with existing cardiovascular conditions should be monitored closely.\n*   **Immunosuppression:** Fluticasone, an inhaled corticosteroid, can cause local immunosuppression in the mouth and throat, leading to an increased risk of oral candidiasis (thrush). Patients should rinse their mouth with water after each use of the inhaler to minimize this risk.\n*   **Pneumonia:** Inhaled corticosteroids may increase the risk of pneumonia, especially in patients with COPD.\n*   **Adrenal Suppression:** While less likely with inhaled corticosteroids than with oral steroids, long-term use can potentially lead to adrenal suppression.\n*   **Bone Density Loss:** Long-term use of inhaled corticosteroids can contribute to bone density loss.\n\n**Important Considerations:**\n\n*   **Social Support:** The patient reports social isolation and limited social contact. Connecting the patient with resources and support services for survivors of intimate partner violence is crucial.\n*   **Mental Health Screening:** Given the history of abuse, regular mental health screening is important.\n\n**Recommendations:**\n\n*   **Assess Medication Adherence:** Inquire about any difficulties the patient may be experiencing in taking their medication as prescribed.\n*   **Counseling and Support:** Provide information about resources for victims of intimate partner violence, including local shelters, support groups, and legal aid.\n*   **Monitor for Side Effects:** Regularly assess the patient for any adverse effects of Fluticasone/Salmeterol, such as oral candidiasis or signs of respiratory infection.\n*   **Mental Health Support:** Offer mental health support and monitor for signs of depression, anxiety, or PTSD.\n*   **Safe Medication Storage:** Discuss safe medication storage practices, considering the patient's living situation.\n*   **Fall Risk:** Review medications and other fall risk factors for the patient.\n\n**Disclaimer:** This information is intended for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 30,
        "patient_id": "b734c85d-0a1e-4d03-8b89-c19d2a6a1157",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Not in labor force (finding) taking Amoxicillin 250 MG / Clavulanate 125 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 molfunc_protein 5515.",
        "llm_answer": "Here are some considerations regarding Amoxicillin/Clavulanate use in a patient who is not in the labor force:\n\n*   **Allergic Reactions:** Amoxicillin is a penicillin-type antibiotic. The most important risk is a potential allergic reaction, which can range from a mild rash to a severe, life-threatening anaphylactic reaction.\n*   **Gastrointestinal Side Effects:** This combination can commonly cause gastrointestinal issues such as nausea, vomiting, and diarrhea.\n*   **Clostridioides difficile-associated Diarrhea (CDAD):** Antibiotics can disrupt the normal gut flora, leading to an overgrowth of *Clostridioides difficile*. This can result in diarrhea, which can range from mild to severe and even be life-threatening.\n*   **Drug Interactions:** Amoxicillin/Clavulanate can interact with other medications.\n*   **Kidney Function:** Since the patient has some high Creatinine values and reduced GFR values, kidney function may be impaired. Amoxicillin is cleared by the kidneys, so impaired kidney function can lead to drug accumulation and increased risk of side effects.\n*   **Financial considerations**: As the patient is not in the labor force, they may face financial challenges in accessing and affording healthcare and medications. It's important to consider the cost of the medication and any potential follow-up care.\n\n**Disclaimer:** This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.\n",
        "rag_answer": "This query cannot be answered using the available information. The patient's chloride level is within normal range (98-106 mmol/L). Furthermore, the knowledge graph does not contain any information about how chloride levels might progress in patients with prediabetes.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 31,
        "patient_id": "e8503522-82ff-67a2-4dad-29281d6318de",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Urea Nitrogen: 19.0 progress for a patient with Victim of intimate partner abuse (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. My knowledge base does not contain information about how intimate partner abuse might affect Urea Nitrogen levels.\n",
        "rag_answer": "I cannot answer the question about how the symptom Body Weight: 83.2 might progress for a patient with Chronic sinusitis (disorder) based on the provided information. The provided knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556), and does not contain information about the typical progression of body weight in patients with chronic sinusitis.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 32,
        "patient_id": "323a0bc9-41a7-bd5c-c431-eab5dca111f5",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Social isolation (finding) taking 0.25 ML Leuprolide Acetate 30 MG/ML Prefilled Syringe? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph, here are some risks to consider for a patient with social isolation taking leuprolide acetate:\n\n*   **Contraindications:** DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.\n    (It's important to look up the specific meanings of these codes (5044, 1200_1134_15512_5080_100078, and 992) to understand the exact nature of the contraindications but I don't have enough information to do so).",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph contains information about drug interactions and contraindications for a drug with ID DB01556, but it does not provide specific risks associated with \"Not in labor force (finding)\" or Acetaminophen 325 MG Oral Tablet.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 33,
        "patient_id": "6c590adb-27ed-cd72-963c-dd6ef39be384",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Diastolic Blood Pressure: 91.7 progress for a patient with Received certificate of high school equivalency (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I am unable to answer this question. The provided knowledge graph excerpt does not contain information about how diastolic blood pressure might progress for a patient with a high school equivalency certificate.\n",
        "rag_answer": "Ibuprofen (DB01556) has several contraindications that should be considered. The provided knowledge graph lists the following: 5044, 1200_1134_15512_5080_100078, and 992. Unfortunately, without more information about what these codes represent, I cannot provide specific details on the risks associated with these contraindications. You should consult with a healthcare professional or pharmacist for a comprehensive review of the risks of taking ibuprofen, especially considering the patient's acute bronchitis and other conditions.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 34,
        "patient_id": "1e7cdf67-1787-d1f1-5dbf-ee25aea4b493",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Viral sinusitis (disorder) taking Naproxen sodium 220 MG Oral Tablet?",
        "llm_answer": "Based on the information available, here are some risks to consider for a patient with viral sinusitis taking Naproxen Sodium:\n\n*   **Gastrointestinal Issues:** Naproxen, like other NSAIDs, can cause stomach upset, ulcers, and bleeding.\n*   **Cardiovascular Risks:** NSAIDs can increase the risk of heart attack or stroke, especially with long-term use or in those with existing heart conditions.\n*   **Kidney Problems:** Naproxen can affect kidney function, particularly in individuals with pre-existing kidney disease or those taking certain medications.\n*   **Allergic Reactions:** Some individuals may be allergic to naproxen.\n*   **Drug Interactions:** Naproxen can interact with other medications, such as blood thinners or certain blood pressure medications.\n*   **Exacerbation of Sinusitis:** In rare cases, NSAIDs can worsen sinus inflammation.\n\nGiven the patient's conditions and medications, it's important to consider the following:\n\n*   The patient has chronic sinusitis and acute bronchitis in addition to viral sinusitis, so additional risks of taking the medication should be considered.\n*   The patient is also taking amoxicillin and acetaminophen. Risks of taking these medications in conjunction with naproxen should be considered.\n\n**Disclaimer:** This information should not be considered medical advice and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of any medical condition.",
        "rag_answer": "Here are some risks to consider for a patient with chronic sinusitis taking Naproxen Sodium:\n\n*   **Gastrointestinal Issues:** Naproxen, like other NSAIDs, can increase the risk of stomach ulcers, bleeding, and perforation. The risk is higher in older adults and those with a history of ulcers or GI bleeding.\n*   **Cardiovascular Risks:** NSAIDs can increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. This risk may increase with the duration of use. Patients with pre-existing cardiovascular disease may be at greater risk.\n*   **Kidney Problems:** Long-term use of NSAIDs can lead to kidney damage, including acute kidney injury and chronic kidney disease.\n*   **Increased Blood Pressure:** Naproxen can lead to new onset or worsening of pre-existing hypertension.\n*   **Allergic Reactions:** Although less common, Naproxen can cause allergic reactions, including skin rash, hives, and anaphylaxis.\n*   **Interactions with Other Medications:** Naproxen can interact with other medications, such as blood thinners (e.g., warfarin), aspirin, and certain antidepressants.\n*   **Exacerbation of Sinusitis:** In rare cases, NSAIDs can exacerbate respiratory conditions, including sinusitis.\n*   **Fluid Retention and Edema:** NSAIDs can cause fluid retention, which may be a concern for individuals with certain medical conditions.\n*   **Age:** The risk of adverse events from NSAIDs, including Naproxen, increases with age.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 35,
        "patient_id": "d846a69a-fa5a-7d43-c0c5-c4c1ef578f54",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Potassium: 3.7 progress for a patient with Stress (finding)? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer the question because the provided knowledge graph is empty, so I don't have the ability to reason about the relationship between Potassium levels and Stress.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain any information about how part-time employment might affect hematocrit levels. The knowledge graph focuses on drug interactions and contraindications for a specific drug (DB01556).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 36,
        "patient_id": "5f26a8b2-4d58-59ef-c264-8d189ed7a933",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Tobacco smoking status NHIS: Never smoker progress for a patient with Not in labor force (finding)?",
        "llm_answer": "As a medical assistant, I am not qualified to provide a diagnosis or predict how a condition might progress.\n",
        "rag_answer": "The symptom \"Which race(s) are you?: White\" is not a symptom that can progress. It is a demographic characteristic indicating the patient's race as White. First-degree burns primarily affect the outer layer of skin (epidermis). The typical progression of a first-degree burn involves:\n\n1.  **Initial appearance:** Redness, mild pain, and dry skin.\n2.  **Healing:** The burn usually heals within a week without scarring. The skin may peel as part of the healing process.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 37,
        "patient_id": "d8e88617-b8f0-d89f-b4f0-abdde20c59db",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Fall risk total [Morse Fall Scale]: 23.0 progress for a patient with Facial laceration? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "I cannot answer this question with the information provided. The provided knowledge graph appears to contain drug contraindications which is not helpful to the question.\n",
        "rag_answer": "Based on the provided information, I can offer some potential risks to consider for a patient with stress taking Galantamine:\n\n*   **Contraindications:** The knowledge graph indicates several contraindications for Galantamine (DB01556), represented by numerical codes. Unfortunately, without knowing what these codes (5044, 1200_1134_15512_5080_100078, 992, etc.) represent, I cannot provide specific details about these contraindications. You would need to consult a medical professional or a database that deciphers these codes to understand the exact nature of these risks.\n*   **Drug-Drug Interactions:** The knowledge graph lists numerous potential drug-drug interactions between Galantamine (DB01556) and other drugs (DB00328, DB00461, etc.). Again, without knowing the names of the drugs represented by these codes, I cannot determine if the patient is taking any of these medications. You would need to check the patient's medication list against a drug interaction database to identify any potential interactions.\n\n**Additional Considerations Based on Patient Profile:**\n\n*   **Stress:** While not a direct contraindication, the patient's stress levels should be monitored.\n*   **Other Conditions and Medications:** A comprehensive review of all the patient's conditions and medications is crucial to identify any potential risks or interactions associated with Galantamine.\n\n**Disclaimer:** I am an AI assistant and cannot provide medical advice. This information is for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 38,
        "patient_id": "2fc1d429-375b-22be-1a5f-f07fa3eaba62",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Hypertension taking amLODIPine 2.5 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 5009.",
        "llm_answer": "Based on the knowledge graph, amLODIPine (DB01556) has the following contraindications:\n\n*   5044\n*   1200_1134_15512_5080_100078\n*   5009\n\nI am unable to provide more specific information on what these contraindications mean. Please consult with a healthcare professional.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph describes drug interactions and contraindications for a drug identified as DB01556. To provide risks specific to amLODIPine for a patient with a history of drug overdose, I would need information about amLODIPine interactions and contraindications.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 39,
        "patient_id": "8702b04b-d1f1-fb3f-7787-dd74b3ddd8c3",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Diastolic Blood Pressure: 80.0 progress for a patient with Reports of violence in the environment (finding)? Based on the knowledge graph which includes facts such as: 4878 disease_protein 5010; 4878 disease_protein 13544_15001_12828_14156_13545_12677_13513_14155_12816_11857_13530_12678_14340_12066_18054_12167_13100; 4878 molfunc_protein 5515.",
        "llm_answer": "I cannot predict how \"Diastolic Blood Pressure: 80.0\" might progress specifically for a patient with \"Reports of violence in the environment (finding)\" based on the provided knowledge graph. The provided facts relate disease to protein and molecular function of protein, but does not have information on how violence in the environment might affect diastolic blood pressure.\n",
        "rag_answer": "I'm sorry, but the provided knowledge graph does not contain information about the risks associated with \"Received higher education (finding)\" or \"Vitamin B 12 5 MG/ML Injectable Solution\". Therefore, I cannot answer your question.",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 40,
        "patient_id": "8dc2f066-f116-0180-277f-d4670b7caa6d",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Transport problems (finding) taking Memantine hydrochloride 2 MG/ML Oral Solution? Based on the knowledge graph which includes facts such as: 1541 drug_effect DB01024; 1541 drug_effect DB01165; 1541 drug_effect DB01137.",
        "llm_answer": "I cannot directly answer this question. The provided knowledge graph only contains drugbank IDs, which I cannot use to determine risks of Memantine hydrochloride.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about the risks of Memantine hydrochloride 2 MG/ML Oral Solution (DB00959). The knowledge graph only contains information about contraindications of Memantine (DB00959).\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 41,
        "patient_id": "1f3ccd29-4283-4d48-eec4-0b501cb2abfd",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Full-time employment (finding) taking Ibuprofen 200 MG Oral Tablet? Based on the knowledge graph which includes facts such as: 43 disease_protein 5384; 6355 bioprocess_protein 5515; 6355 bioprocess_protein 468.",
        "llm_answer": "I am unable to answer this question as I do not have enough information to answer. I can generate human-like text in response to a wide range of prompts and questions, but my knowledge about this topic is limited.\n",
        "rag_answer": "Based on the provided information, here are some risks to consider for a patient with limited social contact taking Acetaminophen/oxyCODONE:\n\n*   **Drug Interactions:** Acetaminophen/oxyCODONE has drug-drug interactions with DB00396.\n*   **Contraindications:** Acetaminophen/oxyCODONE is contraindicated with 5015 and 6920.\n*   **Exposure to Disease:** D008628, D002104 and D003634 are exposure to disease with 6920 and 5015.\n*   **Disease association:** 43 and 1621 disease are associated with 956 and 5384 proteins.\n\nIt's important to note that this information is based solely on the provided data. A comprehensive risk assessment should involve a thorough review of the patient's medical history, a physical examination, and potentially further investigation.\n",
        "base_correct": false,
        "rag_correct": true
    },
    {
        "question_id": 42,
        "patient_id": "71d3115d-9b63-349a-c539-8e46f54d0397",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Has a criminal record (finding) taking Nitroglycerin 0.4 MG/ACTUAT Mucosal Spray? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Here are some risks to consider for a patient with a criminal record taking Nitroglycerin:\n\n*   **Drug Interactions:** Nitroglycerin can interact with other medications, potentially leading to contraindications. It is important to consult your doctor about potential drug interactions.\n*   **Specific Contraindications:** Nitroglycerin has specific contraindications, including interactions represented by codes such as 5044, 1200_1134_15512_5080_100078 and 992.\n*   **General Contraindications:** Nitroglycerin also has general contraindications (represented by code 5044) that should be considered.\n\n**Disclaimer:** This information is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any questions you may have regarding your health or treatment.",
        "rag_answer": "I cannot answer the question about the risks of taking Simvastatin 20 MG Oral Tablet, since the knowledge graph only contains information about drug interactions and contraindications for a drug with ID DB01556, but not about Simvastatin.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 43,
        "patient_id": "d5fcf85c-fbb4-e758-7018-58d168b39a82",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Acute respiratory distress syndrome (disorder) taking 4 ML norepinephrine 1 MG/ML Injection?",
        "llm_answer": "Based on the patient's profile and the medications they are taking, here are some risks to consider for a patient with Acute Respiratory Distress Syndrome (ARDS) taking norepinephrine:\n\n*   **Norepinephrine Risks in ARDS:** Norepinephrine is a vasopressor used to increase blood pressure in hypotensive patients. In ARDS, it's often used to maintain adequate blood pressure to perfuse vital organs. However, it comes with risks:\n    *   **Increased Pulmonary Shunt:** Vasopressors like norepinephrine can increase pulmonary shunt in ARDS, potentially worsening oxygenation.\n    *   **Cardiac Arrhythmias:** Norepinephrine can increase the risk of cardiac arrhythmias, especially in patients with underlying heart conditions or electrolyte imbalances.\n    *   **Peripheral Ischemia:** Norepinephrine can cause vasoconstriction, potentially leading to peripheral ischemia, especially in the extremities.\n    *   **Myocardial Dysfunction:** High doses of norepinephrine can increase myocardial oxygen demand and potentially lead to myocardial dysfunction.\n    *   **Extravasation:** Norepinephrine is a vesicant, meaning that extravasation (leakage into surrounding tissues) can cause tissue damage and necrosis. It should be administered through a central line when possible.\n    *   **Interactions:** Norepinephrine can interact with other medications.\n*   **Patient-Specific Risks**\n    *   **Sepsis:** The patient has sepsis, which can increase the risk of arrhythmias and other adverse effects from norepinephrine. Sepsis-induced myocardial dysfunction may also be exacerbated.\n    *   **Hypoxemia:** Given the oxygen saturation of 92.0, the patient likely has hypoxemia, which can increase the risk of cardiac arrhythmias and other adverse effects from norepinephrine.\n    *   **Acidosis:** The patient has a lactate of 2.2 and 3.2. Elevated lactate levels may indicate metabolic acidosis, which can reduce the effectiveness of norepinephrine and increase the risk of arrhythmias.\n*   **General ARDS Risks:** Besides the norepinephrine-specific risks, it is important to be aware of general risks related to ARDS:\n    *   **Ventilator-Induced Lung Injury (VILI):** ARDS patients often require mechanical ventilation, which can cause further lung injury. Strategies such as low tidal volume ventilation and positive end-expiratory pressure (PEEP) are used to minimize VILI.\n    *   **Secondary Infections:** ARDS patients are at increased risk of secondary infections, such as ventilator-associated pneumonia (VAP).\n    *   **Barotrauma/Pneumothorax:** Mechanical ventilation can cause lung overdistension, leading to barotrauma or pneumothorax.\n    *   **Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE):** ARDS patients are often immobile, increasing the risk of DVT and PE.\n    *   **Multi-Organ Failure:** ARDS can lead to multi-organ failure, especially in the context of sepsis.\n    *   **Delirium:** ICU stays and medications can contribute to delirium, which can have long-term cognitive consequences.\n    *   **Psychological Sequelae:** ARDS survivors are at risk of anxiety, depression, and post-traumatic stress disorder (PTSD).\n",
        "rag_answer": "Based on the patient's profile and the medication piperacillin/tazobactam, here are the risks to consider:\n\n*   **Sepsis and ARDS:** The patient has diagnoses of sepsis and acute respiratory distress syndrome (ARDS). Antibiotics like piperacillin/tazobactam are often used to treat sepsis, but it's important to monitor for signs of worsening infection or complications related to ARDS.\n\n*   **Kidney Function:** Piperacillin/tazobactam can affect kidney function.\n\n*   **Allergic Reactions:** Allergic reactions are a risk with any antibiotic, including piperacillin/tazobactam.\n\n*   **Clostridioides difficile Infection:** Antibiotics can disrupt the normal gut flora, leading to *Clostridioides difficile* infection.\n\n*   **Drug Interactions:** Review the patient's other medications (acetaminophen, vancomycin, norepinephrine) for potential interactions with piperacillin/tazobactam.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 44,
        "patient_id": "1ded4f39-fa12-544b-0a17-1050427df77b",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Erythrocytes [#/volume] in Blood by Automated count: 4.0 progress for a patient with Suspected lung cancer (situation)? Based on the knowledge graph which includes facts such as: R-HSA-450513 pathway_protein 11340; R-HSA-450513 pathway_protein 118460; R-HSA-450513 pathway_protein 22894.",
        "llm_answer": "I am sorry, but I cannot predict how the symptom \"Erythrocytes [#/volume] in Blood by Automated count: 4.0\" might progress for a patient with suspected lung cancer based on the provided information. The provided facts about R-HSA-450513 pathway proteins are not directly related to the progression of erythrocyte count in lung cancer. To predict the progression of this symptom, I would need information about the specific type and stage of lung cancer, the patient's overall health status, and any treatments they are receiving.\n",
        "rag_answer": "I am unable to answer this question. The provided knowledge graph does not contain information about risks associated with taking PACLitaxel 100 MG Injection while having Hypertriglyceridemia (disorder).\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 45,
        "patient_id": "49325aa6-5655-1d1f-5745-46902c91f3b9",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Stress is when someone feels tense  nervous  anxious or can't sleep at night because their mind is troubled. How stressed are you?: Somewhat progress for a patient with Victim of intimate partner abuse (finding)? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; 348 disease_protein 5010.",
        "llm_answer": "The patient's reported stress level of \"Somewhat\" could potentially worsen if they are experiencing intimate partner abuse. Here's why, and how that might manifest:\n\n*   **Intimate Partner Abuse and Stress:** Being a victim of intimate partner abuse is a significant stressor. The abuse can be physical, emotional, psychological, or financial, all of which contribute to a heightened stress response.\n*   **Potential Progression:** The patient's stress could progress from \"Somewhat\" to \"Quite a bit\" or \"Very much\" if the abuse continues or escalates.\n*   **Impact on Mental Health:** Increased stress can exacerbate the patient's anxiety and potentially contribute to depressive symptoms.\n*   **Physical Health Implications:** Chronic stress can have negative effects on physical health, potentially worsening conditions like fibromyalgia and chronic low back pain. It can also impact blood pressure, sleep, and overall well-being.\n\nIt's important to assess the patient's safety and provide resources for intimate partner violence.\n",
        "rag_answer": "Based on the provided information, I cannot determine how Urea Nitrogen levels specifically progress in Alzheimer's disease. The knowledge graph provides associations between a disease (represented by a number, possibly an identifier) and proteins. The patient's symptoms include a Urea Nitrogen level of 17.8. However, there's no direct link established between Alzheimer's and Urea Nitrogen levels or their progression in the provided data. More specific medical knowledge would be needed to answer this question accurately.\n",
        "base_correct": false,
        "rag_correct": false
    },
    {
        "question_id": 46,
        "patient_id": "ac643af6-1a32-08ce-df40-1c31348bcb41",
        "question_type": "RISK_ASSESSMENT",
        "question": "What risks should be considered for a patient with Fracture of forearm taking Acetaminophen 325 MG Oral Tablet? Based on the knowledge graph which includes facts such as: DB01556 contraindication 5044; DB01556 contraindication 1200_1134_15512_5080_100078; DB01556 contraindication 992.",
        "llm_answer": "Based on the knowledge graph provided, here are some risks to consider for a patient with a fracture of the forearm taking Acetaminophen 325 MG Oral Tablet:\n\n*   **DB01556 contraindication 5044:** This suggests a general contraindication that needs further clarification based on what \"5044\" refers to in the knowledge graph.\n*   **DB01556 contraindication 1200\\_1134\\_15512\\_5080\\_100078:** This suggests a general contraindication that needs further clarification based on what \"1200\\_1134\\_15512\\_5080\\_100078\" refers to in the knowledge graph.\n*   **DB01556 contraindication 992:** This suggests a general contraindication that needs further clarification based on what \"992\" refers to in the knowledge graph.\n\n**Please Note:** The information provided is based solely on the limited knowledge graph data. To provide a comprehensive risk assessment, it is essential to know what the codes \"5044\", \"1200\\_1134\\_15512\\_5080\\_100078\" and \"992\" refer to within the knowledge graph.\n",
        "rag_answer": "Based on the provided information:\n\n*   **Lisinopril (DB01556) Contraindications:** The knowledge graph lists several contraindications for Lisinopril (DB01556), represented by numerical codes. Without knowing what these codes signify, it's impossible to determine the specific risks.\n\nIt is important to consult with a healthcare professional or refer to comprehensive medical databases for detailed information on Lisinopril contraindications and potential risks associated with appendicitis.\n",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 47,
        "patient_id": "f7019a56-1940-b131-f5e2-39439c16a942",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Diastolic Blood Pressure: 74.0 progress for a patient with Chronic sinusitis (disorder)? Based on the knowledge graph which includes facts such as: 348 disease_protein 21187_11237_11470; 348 disease_protein 1336; DB00304 contraindication 5347.",
        "llm_answer": "I cannot determine how Diastolic Blood Pressure: 74.0 might progress for a patient with Chronic sinusitis (disorder) using the knowledge graph provided. The knowledge graph only contains facts about disease-protein relationships and drug contraindications, which are not directly related to the progression of diastolic blood pressure in patients with chronic sinusitis.\n",
        "rag_answer": "Based on the provided information:\n\n*   **Albuterol (NDA020503)**: From the knowledge graph, DB00153 represents Albuterol.\n*   **Stress (finding)**: Stress is associated with the code 5347.\n\nThe knowledge graph states \"DB00153 contraindication 21187\\_11237\\_11470\" and \"DB00153 contraindication 1336\". However, there is no direct link found in the knowledge graph indicating a contraindication between Albuterol (DB00153) and Stress (5347). Therefore, the risks related to Stress and Albuterol cannot be determined.",
        "base_correct": true,
        "rag_correct": true
    },
    {
        "question_id": 48,
        "patient_id": "322ab10f-3c76-7f32-7581-d96e262518c2",
        "question_type": "SYMPTOM_PROGRESSION",
        "question": "How might the symptom Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26.5 progress for a patient with Non-small cell carcinoma of lung  TNM stage 1 (disorder)?",
        "llm_answer": "The progression of alanine aminotransferase (ALT) levels in a patient with non-small cell lung cancer (NSCLC) TNM stage 1 can vary. Here's how it might progress, considering potential factors:\n\n*   **No Change:** At stage 1, if the tumor isn't directly affecting the liver or causing systemic inflammation, ALT levels might remain relatively stable and within the normal range.\n*   **Slight Elevation:** Minimal elevations in ALT could occur due to:\n\n    *   **Medications:** Chemotherapy drugs like Cisplatin and Paclitaxel can cause liver injury, leading to elevated ALT levels.\n    *   **Metastasis:** Lung cancer can spread to the liver, even at Stage 1, which could cause increased ALT.\n*   **Significant Elevation:** More significant increases in ALT could indicate:\n\n    *   **Advanced Metastasis:** More widespread liver involvement by the cancer.\n    *   **Drug-Induced Liver Injury:** A more pronounced reaction to chemotherapy or other medications.\n    *   **Other Liver Conditions:** The patient may develop a separate liver condition unrelated to the cancer.",
        "rag_answer": "I am unable to answer this question. The provided information does not contain any risks associated with Received certificate of high school equivalency (finding) taking Acetaminophen 325 MG Oral Tablet.",
        "base_correct": false,
        "rag_correct": false
    }
]